# EDGAR Filing Document

**Accession Number:** 0001979330
**File Stem:** 0001104659-26-057822
**Filing Date:** 2026-5
**Character Count:** 207354
**Document Hash:** 4e594ffde64433b4906014fb968031cd
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-057822.hdr.sgml**: 20260508

**ACCESSION NUMBER**: 0001104659-26-057822

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 89

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260508

**DATE AS OF CHANGE**: 20260508

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NB Bancorp, Inc.
- **CENTRAL INDEX KEY:** 0001979330
- **STANDARD INDUSTRIAL CLASSIFICATION:** SAVINGS INSTITUTIONS, NOT FEDERALLY CHARTERED [6036]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 932560883
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41899
- **FILM NUMBER:** 26957777

**BUSINESS ADDRESS:**
- **STREET 1:** 1063 GREAT PLAIN AVENUE
- **CITY:** NEEDHAM
- **STATE:** MA
- **ZIP:** 02492
- **BUSINESS PHONE:** 781-444-2100

**MAIL ADDRESS:**
- **STREET 1:** 1063 GREAT PLAIN AVENUE
- **CITY:** NEEDHAM
- **STATE:** MA
- **ZIP:** 02492

?xml version='1.0' encoding='ASCII'? NB Bancorp, Inc._March 31, 2026

[**Table of Contents**](#TOC)

------

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 10-Q**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;☒ Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended March 31, 2026

**OR**

☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from _______________ to _______________

**Commission File No. 001-41899**

**NB Bancorp, Inc.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Maryland** | **93-2560883** |
| (State or other jurisdiction of<br>incorporation or organization) | (I.R.S. Employer<br>Identification Number) |
| **1063 Great Plain AvenueNeedham, Massachusetts** | **02492** |
| (Address of Principal Executive Offices) | (Zip Code) |

---

**(781) 444-2100**

(Registrant's telephone number)

**N/A**

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Common stock, par value $0.01 per share** | **NBBK** | **The NASDAQ Stock Market, LLC** |
| (Title of each class to be registered)<br>| (Ticker Symbol) | (Name of each exchange on which<br>each class is to be registered) |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such requirements for the past 90 days.

YES ☒&nbsp;&nbsp;&nbsp;&nbsp; NO ☐

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).

YES ☒&nbsp;&nbsp;&nbsp;&nbsp; NO ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act:

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Large accelerated filer ☐ | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accelerated filer ☒ |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-accelerated filer ☐ | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Smaller reporting company ☐ |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Emerging growth company ☒ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Act). YES ☐ NO ☒

As of April 30, 2026, 44,706,163 shares of the Registrant's common stock, par value $0.01 per share, were issued and outstanding.

------

[**Table of Contents**](#TOC)

**NB Bancorp, Inc.**

**Form 10-Q**

Index

---

| | | |
|:---|:---|:---|
|  |  | **Page** |
| [**Part I. Financial Information**](#BalanceSheet) | [**Part I. Financial Information**](#BalanceSheet) |  |
| [Item 1.](#BalanceSheet) | [Consolidated Financial Statements](#BalanceSheet) |  |
|  | [Consolidated Balance Sheets as of March 31, 2026 (unaudited) and December 31, 2025](#BalanceSheet) | 1 |
|  | [Consolidated Statements of Income for the Three Months Ended March 31, 2026 and 2025 (unaudited)](#StatementsofIncome) | 2 |
|  | [Consolidated Statements of Comprehensive Income for the Three Months Ended March 31, 2026 and 2025 (unaudited)](#StatementsofOCI) | 3 |
|  | [Consolidated Statements of Changes in Shareholders' Equity for the Three Months Ended March 31, 2026 and 2025 (unaudited)](#StatementofEquity) | 4 |
|  | [Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2026 and 2025 (unaudited)](#StatementsofCashFlows) | 5 |
|  | [Notes to Consolidated Financial Statements (unaudited)](#NotestoCondensedConsolidatedFinancialSta) | 7 |
| [Item 2.](#Item2ManagementsDiscussionandAnalysisofF) | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#Item2ManagementsDiscussionandAnalysisofF) | 37 |
| [Item 3.](#Item3QuantitativeandQualitativeDisclosur) | [Quantitative and Qualitative Disclosures about Market Risk](#Item3QuantitativeandQualitativeDisclosur) | 49 |
| [Item 4.](#Item4ControlsandProcedures_577182) | [Controls and Procedures](#Item4ControlsandProcedures_577182) | 49 |
| [**Part II. Other Information**](#PartIIOtherInformation_842346) | [**Part II. Other Information**](#PartIIOtherInformation_842346) |  |
| [Item 1.](#Item1LegalProceedings_250329) | [Legal Proceedings](#Item1LegalProceedings_250329) | 49 |
| [Item 1A.](#Item1ARiskFactors_237303) | [Risk Factors](#Item1ARiskFactors_237303) | 49 |
| [Item 2.](#Item2UnregisteredSalesofEquitySecurities) | [Unregistered Sales of Equity Securities and Use of Proceeds](#Item2UnregisteredSalesofEquitySecurities) | 49 |
| [Item 3.](#Item3DefaultsUponSeniorSecurities_803231) | [Defaults upon Senior Securities](#Item3DefaultsUponSeniorSecurities_803231) | 49 |
| [Item 4.](#Item4MineSafetyDisclosures_3831) | [Mine Safety Disclosures](#Item4MineSafetyDisclosures_3831) | 49 |
| [Item 5.](#Item5OtherInformation_831596) | [Other Information](#Item5OtherInformation_831596) | 50 |
| [Item 6.](#Item6Exhibits_655382) | [Exhibits](#Item6Exhibits_655382) | 50 |
|  | [Signature Page](#SIGNATURES_406224) | 51 |

---

[**Table of Contents**](#TOC)

---

| | | |
|:---|:---|:---|
| **Part I. – Financial Information** | **Part I. – Financial Information** | **Part I. – Financial Information** |
| **Item 1. Financial Statements** |  |  |
| **NB Bancorp, Inc.** | **NB Bancorp, Inc.** | **NB Bancorp, Inc.** |
| **Consolidated Balance Sheets** | **Consolidated Balance Sheets** | **Consolidated Balance Sheets** |
| **March 31, 2026 (Unaudited) and December 31, 2025** | **March 31, 2026 (Unaudited) and December 31, 2025** | **March 31, 2026 (Unaudited) and December 31, 2025** |
| **(in thousands except share and per share data)** | **(in thousands except share and per share data)** | **(in thousands except share and per share data)** |
|  | **March 31, 2026** | **December 31, 2025** |
| **Assets** |  |  |
| Cash and due from banks | $327739 | $325711 |
| Federal funds sold | 47618 | 81885 |
| &nbsp;&nbsp;Total cash and cash equivalents | 375357 | 407596 |
| Available-for-sale securities, at fair value | 277241 | 268959 |
| Loans held for sale, at fair value | 63971 | 66447 |
| Loans receivable, net of deferred fees | 6209910 | 5986140 |
| Allowance for credit losses | (80195) | (87411) |
| &nbsp;&nbsp;Net loans | 6129715 | 5898729 |
| Accrued interest receivable | 27150 | 25390 |
| Banking premises and equipment, net | 47335 | 46209 |
| Non-public investments | 40738 | 33740 |
| Bank-owned life insurance ("BOLI") | 110586 | 104335 |
| Prepaid expenses and other assets | 67749 | 68079 |
| Goodwill | 18512 | 18512 |
| Core deposit intangible, net | 18411 | 19303 |
| Deferred income tax asset, net | 49672 | 48831 |
| &nbsp;&nbsp;**Total assets** | $7226437 | $7006130 |
| **Liabilities and shareholders' equity** |  |  |
| Deposits |  |  |
| &nbsp;&nbsp;Core deposits | $5526936 | $5317853 |
| &nbsp;&nbsp;Brokered deposits | 570052 | 535681 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total deposits | 6096988 | 5853534 |
| Mortgagors' escrow accounts | 4858 | 5193 |
| Federal Home Loan Bank ("FHLB") borrowings | 189701 | 196235 |
| Accrued expenses and other liabilities | 70983 | 70716 |
| Accrued retirement liabilities | 21129 | 21520 |
| &nbsp;&nbsp;**Total liabilities** | 6383659 | 6147198 |
| **Shareholders' equity:** |  |  |
| Preferred stock, $0.01 par value, 5,000,000 shares authorized; no shares issued and outstanding |  |  |
| Common stock, $0.01 par value, 120,000,000 shares authorized; 44,765,178 and 45,770,128 |  |  |
| &nbsp;&nbsp;shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 448 | 458 |
| Additional paid-in capital | 432858 | 458864 |
| Unallocated common shares held by the Employee Stock Ownership Plan ("ESOP") | (41873) | (42454) |
| Retained earnings | 456978 | 445200 |
| Accumulated other comprehensive loss | (5633) | (3136) |
| &nbsp;&nbsp;**Total shareholders' equity** | 842778 | 858932 |
| &nbsp;&nbsp;**Total liabilities and shareholders' equity** | $7226437 | $7006130 |

---

The accompanying notes are an integral part of these unaudited consolidated financial statements.

[**Table of Contents**](#TOC)

---

| | | |
|:---|:---|:---|
| **NB Bancorp, Inc.** | **NB Bancorp, Inc.** | **NB Bancorp, Inc.** |
| **Consolidated Statements of Income** | **Consolidated Statements of Income** | **Consolidated Statements of Income** |
| **(Unaudited - Dollars in thousands, except per share data)** | **(Unaudited - Dollars in thousands, except per share data)** | **(Unaudited - Dollars in thousands, except per share data)** |
|  | **For the Three Months Ended**  | **For the Three Months Ended**  |
|  | **March 31,**  | **March 31,**  |
|  | **2026** | **2025** |
| **INTEREST AND DIVIDEND INCOME** |  |  |
| Interest and fees on loans | $100042 | $71440 |
| Interest on securities | 2708 | 2290 |
| Interest and dividends on cash equivalents and other | 2936 | 3121 |
| &nbsp;&nbsp;Total interest and dividend income | 105686 | 76851 |
| **INTEREST EXPENSE** |  |  |
| Interest on deposits | 39579 | 32239 |
| Interest on borrowings | 1239 | 1086 |
| &nbsp;&nbsp;Total interest expense | 40818 | 33325 |
| **NET INTEREST INCOME** | 64868 | 43526 |
| **PROVISION FOR CREDIT LOSSES** |  |  |
| Provision for credit losses - loans | 6382 | 947 |
| (Release of) provision for credit losses - unfunded commitments | (54) | 211 |
| &nbsp;&nbsp;Total provision for credit losses | 6328 | 1158 |
| **NET INTEREST INCOME AFTER PROVISION FOR CREDIT LOSSES** | 58540 | 42368 |
| **NONINTEREST INCOME** |  |  |
| Customer service fees | 3131 | 2558 |
| Increase in cash surrender value of BOLI | 853 | 1031 |
| Mortgage banking income | 119 | 149 |
| Swap contract income | 201 | 88 |
| (Loss) gain on sale of loans, net | (1) | 27 |
| Other income | 210 | 29 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total noninterest income | 4513 | 3882 |
| **NONINTEREST EXPENSE** |  |  |
| Salaries and employee benefits | 25468 | 19149 |
| Director and professional service fees | 4049 | 2148 |
| Occupancy and equipment expenses | 2491 | 1580 |
| Data processing expenses | 4439 | 2765 |
| Marketing and charitable contribution expenses | 1033 | 846 |
| FDIC and state insurance assessments | 1152 | 813 |
| Merger and acquisition expenses | 534 |  |
| General and administrative expenses | 3535 | 1380 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total noninterest expense | 42701 | 28681 |
| **INCOME BEFORE TAXES** | 20352 | 17569 |
| **INCOME TAX EXPENSE** | 5368 | 4914 |
| **NET INCOME** | $14984 | $12655 |
| Weighted average common shares outstanding, basic | 40969748 | 38755746 |
| Weighted average common shares outstanding, diluted | 41421002 | 38755746 |
| Earnings per share, basic | $0.37 | $0.33 |
| Earnings per share, diluted | $0.36 | $0.33 |

---

The accompanying notes are an integral part of these unaudited consolidated financial statements.

[**Table of Contents**](#TOC)

---

| | | |
|:---|:---|:---|
| **NB Bancorp, Inc.** | **NB Bancorp, Inc.** | **NB Bancorp, Inc.** |
| **Consolidated Statements of Comprehensive Income** | **Consolidated Statements of Comprehensive Income** | **Consolidated Statements of Comprehensive Income** |
| **(Unaudited - Dollars in thousands)** | **(Unaudited - Dollars in thousands)** | **(Unaudited - Dollars in thousands)** |
|  | **For the Three Months Ended**  | **For the Three Months Ended**  |
|  | **March 31,**  | **March 31,**  |
|  | **2026** | **2025** |
| **NET INCOME** | $14984 | $12655 |
| **OTHER COMPREHENSIVE INCOME, NET OF TAX:** |  |  |
| &nbsp;&nbsp;Net change in fair value of available-for-sale securities | (1001) | 1702 |
| &nbsp;&nbsp;Net change in fair value of cash flow hedge | (1496) |  |
| **TOTAL OTHER COMPREHENSIVE INCOME, NET OF TAX:** | (2497) | 1702 |
| **TOTAL COMPREHENSIVE INCOME, NET OF TAX** | $12487 | $14357 |

---

The accompanying notes are an integral part of these unaudited consolidated financial statements.

[**Table of Contents**](#TOC)

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **NB Bancorp, Inc.** | **NB Bancorp, Inc.** | **NB Bancorp, Inc.** | **NB Bancorp, Inc.** | **NB Bancorp, Inc.** | **NB Bancorp, Inc.** | **NB Bancorp, Inc.** | **NB Bancorp, Inc.** |
| **Consolidated Statements of Changes in Shareholders' Equity** | **Consolidated Statements of Changes in Shareholders' Equity** | **Consolidated Statements of Changes in Shareholders' Equity** | **Consolidated Statements of Changes in Shareholders' Equity** | **Consolidated Statements of Changes in Shareholders' Equity** | **Consolidated Statements of Changes in Shareholders' Equity** | **Consolidated Statements of Changes in Shareholders' Equity** | **Consolidated Statements of Changes in Shareholders' Equity** |
| **(Unaudited - Dollars in thousands)** | **(Unaudited - Dollars in thousands)** | **(Unaudited - Dollars in thousands)** | **(Unaudited - Dollars in thousands)** | **(Unaudited - Dollars in thousands)** | **(Unaudited - Dollars in thousands)** | **(Unaudited - Dollars in thousands)** | **(Unaudited - Dollars in thousands)** |
|  | **For the Three Months Ended**  | **For the Three Months Ended**  | **For the Three Months Ended**  | **For the Three Months Ended**  | **For the Three Months Ended**  | **For the Three Months Ended**  | **For the Three Months Ended**  |
|  | **Shares of**<br>**Common** <br>**Stock**<br>**Outstanding** | <br><br>**Common Stock** | <br>**Additional** <br>**Paid-In**<br>**Capital** | **Unallocated** <br>**Common**<br>**Stock Held by**<br>**ESOP** | <br>**Retained**<br>**Earnings** | **Accumulated**<br>**Other**<br>**Comprehensive**<br>**Income (Loss)** | <br>**Total** |
| **Balance, December 31, 2024** | 42705729 | $427 | $417247 | $(44813) | $400473 | $(8167) | $765167 |
| Net income |  |  |  |  | 12655 |  | 12655 |
| Other comprehensive income, net of tax |  |  |  |  |  | 1702 | 1702 |
| Repurchase of common shares under share repurchase plan | (2135286) | (21) | (40675) |  |  |  | (40696) |
| ESOP shares committed to be released (42,121 shares) |  |  | 201 | 582 |  |  | 783 |
| **Balance, March 31, 2025** | 40570443 | $406 | $376773 | $(44231) | $413128 | $(6465) | $739611 |
| **Balance, December 31, 2025** | 45770128 | $458 | $458864 | $(42454) | $445200 | $(3136) | $858932 |
| Net income |  |  |  |  | 14984 |  | 14984 |
| Other comprehensive loss, net of tax |  |  |  |  |  | (2497) | (2497) |
| Repurchase of common shares under share repurchase plan | (1288509) | (13) | (27750) |  |  |  | (27763) |
| Restricted stock award issued | 283559 | 3 | (3) |  |  |  |  |
| Stock-based compensation |  |  | 1443 |  |  |  | 1443 |
| ESOP shares committed to be released (42,121 shares) |  |  | 303 | 582 |  |  | 885 |
| Dividends paid |  |  |  |  | (3206) |  | (3206) |
| **Balance, March 31, 2026** | 44765178 | $448 | $432857 | $(41872) | $456978 | $(5633) | $842778 |

---

The accompanying notes are an integral part of these unaudited consolidated financial statements.

[**Table of Contents**](#TOC)

**NB Bancorp, Inc.**

**Consolidated Statements of Cash Flows**

**(Dollars in thousands)**

---

| | | |
|:---|:---|:---|
|  | **For the Three Months Ended March 31,**  | **For the Three Months Ended March 31,**  |
|  | **2026** | **2025** |
| **CASH FLOWS FROM OPERATING ACTIVITIES** |  |  |
| Net income | $14984 | $12655 |
| Adjustments to reconcile net income to net cash from operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Net (accretion) amortization of available-for-sale securities | (55) | 41 |
| &nbsp;&nbsp;&nbsp;Amortization of core deposit intangible | 892 | 37 |
| &nbsp;&nbsp;&nbsp;Provision for credit losses | 6328 | 1158 |
| &nbsp;&nbsp;&nbsp;Loan hedge fair value adjustments, net | 19 | 39 |
| &nbsp;&nbsp;&nbsp;Change in net deferred loan origination fees | 2479 | 233 |
| &nbsp;&nbsp;&nbsp;Loans originated for sale | (2792) | (340) |
| &nbsp;&nbsp;&nbsp;Proceeds from sale of loans held for sale | 2984 | 1384 |
| &nbsp;&nbsp;&nbsp;Gain on sale of loans | (17) | (27) |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization expense | 901 | 693 |
| &nbsp;&nbsp;&nbsp;Gain from BOLI death benefit |  | (25) |
| &nbsp;&nbsp;&nbsp;Increase in cash surrender values of BOLI | (853) | (1006) |
| &nbsp;&nbsp;&nbsp;Deferred income tax benefit | (12) | (9) |
| &nbsp;&nbsp;&nbsp;ESOP expense | 885 | 783 |
| &nbsp;&nbsp;&nbsp;Stock-based compensation | 1443 |  |
| Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Net change in loans held for sale | 3622 |  |
| &nbsp;&nbsp;&nbsp;Accrued interest receivable | (1760) | 152 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other assets | 424 | 3295 |
| &nbsp;&nbsp;&nbsp;Accrued expenses and other liabilities | (1750) | (5575) |
| &nbsp;&nbsp;&nbsp;Accrued retirement liabilities | (391) | (3540) |
| NET CASH PROVIDED BY OPERATING ACTIVITIES | 27331 | 9948 |
| **CASH FLOWS FROM INVESTING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;Loan originations and purchases, net of repayments | (241442) | (134195) |
| &nbsp;&nbsp;&nbsp;Purchases of available-for-sale securities | (34070) | (12808) |
| &nbsp;&nbsp;&nbsp;Proceeds from maturities, calls and paydowns of available-for-sale securities | 24512 | 8583 |
| &nbsp;&nbsp;&nbsp;Recoveries of loans previously charged off | 237 | 205 |
| &nbsp;&nbsp;&nbsp;Net change in non-public investments | (6998) | (346) |
| &nbsp;&nbsp;&nbsp;Proceeds from BOLI death benefit |  | 128 |
| &nbsp;&nbsp;&nbsp;Purchases of BOLI policies | (20000) |  |
| &nbsp;&nbsp;&nbsp;Proceeds from surrender of BOLI policies | 14602 |  |
| &nbsp;&nbsp;&nbsp;Purchases of banking premises and equipment | (2027) | (108) |
| NET CASH USED IN INVESTING ACTIVITIES | (265186) | (138541) |
| **CASH FLOWS FROM FINANCING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;Net change in deposits | 243454 | 148965 |
| &nbsp;&nbsp;&nbsp;Net change in mortgagors' escrow accounts | (335) | (85) |
| &nbsp;&nbsp;&nbsp;Repurchase of common shares under share repurchase plans | (27763) | (40696) |
| &nbsp;&nbsp;&nbsp;Dividends paid | (3206) |  |
| &nbsp;&nbsp;&nbsp;Advances of FHLB borrowings | 415700 |  |
| &nbsp;&nbsp;&nbsp;Paydowns of FHLB borrowings | (422234) | (30000) |
| NET CASH PROVIDED BY FINANCING ACTIVITIES | 205616 | 78184 |
| NET CHANGE IN CASH AND CASH EQUIVALENTS | (32239) | (50409) |
| CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD | 407596 | 363855 |
| CASH AND CASH EQUIVALENTS AT END OF PERIOD | $375357 | $313446 |

---

The accompanying notes are an integral part of these unaudited consolidated financial statements.

[**Table of Contents**](#TOC)

---

| | | |
|:---|:---|:---|
|  | **For the Three Months Ended March 31,**  | **For the Three Months Ended March 31,**  |
|  | **2026** | **2025** |
| Supplemental disclosure of cash paid during the period for: |  |  |
| &nbsp;&nbsp;&nbsp;Interest | $40719 | $36685 |
| &nbsp;&nbsp;&nbsp;Income taxes: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;U.S. Federal |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Massachusetts | 2520 | 2150 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Jurisdictions below 5 percent of total income taxes paid, net of refunds | 185 |  |
| Supplemental disclosure of non-cash transactions: |  |  |
| &nbsp;&nbsp;&nbsp;Initial recognition of operating lease right of use assets and lease liabilities | $1947 | $— |
| &nbsp;&nbsp;&nbsp;Increase in operating lease right of use assets and lease liabilities resulting from lease modifications | 124 |  |
| &nbsp;&nbsp;&nbsp;Unrealized (losses) gains on available-for-sale securities | (1331) | 2291 |
| &nbsp;&nbsp;&nbsp;Unrealized holding losses on cash flow hedge | (1995) |  |
| &nbsp;&nbsp;&nbsp;Mortgage loans transferred to loans held for sale | 1339 | 1017 |
| &nbsp;&nbsp;&nbsp;Restricted stock awards granted | 3 |  |

---

The accompanying notes are an integral part of these unaudited consolidated financial statements.

[**Table of Contents**](#TOC)

**NB Bancorp, Inc.**

#### Notes to Unaudited Consolidated Financial Statements

#### Note 1 – Corporate Structure and Nature of Operations; Basis of Presentation
***Corporate Structure and Nature of Operations***

NB Bancorp, Inc., a Maryland corporation (the "Company"), is a bank holding company. Through its wholly-owned subsidiary, Needham Bank (the "Bank"), the Company provides a variety of banking services, through its full-service bank branches, located primarily in eastern Massachusetts and southern New Hampshire.

The activities of the Company and the Bank are subject to the regulatory supervision of the Board of Governors of the Federal Reserve System and the Massachusetts Commissioner of Banks. The Company and the activities of the Bank and its subsidiaries are also subject to various Massachusetts business and banking regulations.

***Conversion***

Effective December 27, 2023, NB Financial, MHC (the "MHC"), the Bank's former mutual holding company and the predecessor of the Company, converted from a mutual holding company into a publicly traded stock form of organization. In connection with the conversion, the Company sold 40,997,500 shares of common stock in a public offering at $10.00 per share for net offering proceeds of approximately $400.4 million. Additionally, the Company donated $2.0 million of cash and 1,708,229 shares of common stock to the Needham Bank Charitable Foundation (the "Foundation").

In connection with the conversion, liquidation accounts are established by the Company and the Bank in an aggregate amount equal to (i) the MHC's ownership interest in the shareholders' equity of NB Financial, Inc. as of the date of the latest statement of financial condition included in the Company's definitive prospectus dated October 12, 2023, plus (ii) the value of the net assets of the MHC as of the date of the MHC's latest statement of financial condition before the consummation of the Conversion (excluding the MHC's ownership interest in NB Financial, Inc.). Each eligible account holder and supplemental eligible account holder is entitled to a proportionate share of the liquidation accounts in the event of a liquidation of (i) the Company and the Bank or (ii) the Bank, and only in such events. This share will be reduced if the eligible account holder's or supplemental account holder's deposit balance falls below the amounts on the date of record and will cease to exist if the account is closed. The liquidation account will never be increased despite any increase after conversion in the related deposit balance. The Bank may not pay a dividend on its capital stock if the effect thereof would cause retained earnings to be reduced below the liquidation account amount or regulatory capital requirements.

***Basis of Presentation***

The Company's Consolidated Financial Statements have been prepared in conformity with accounting principles generally accepted in the United States ("U.S. GAAP") as set forth by the Financial Accounting Standards Board ("FASB") and its Accounting Standards Codification ("ASC") and Accounting Standards Updates ("ASU") as well as the rules and interpretive releases of the U.S. Securities and Exchange Commission ("SEC") under the authority of federal securities laws.

The Consolidated Financial Statements of the Company include the balances and results of operations of the Company and the Bank, its wholly-owned subsidiary, as well as the Bank's wholly-owned subsidiaries, Needco-op Investment Corporation, Inc., 1892 Investments LLC and Eaton Square Realty LLC. All intercompany accounts and transactions have been eliminated in consolidation.

Certain amounts, previously reported, have been reclassified to state all periods on a comparable basis and had no effect on shareholders' equity or net income.

[**Table of Contents**](#TOC)

The accompanying Consolidated Balance Sheet as of March 31, 2026, the Consolidated Statements of Income, of Comprehensive Income, of Changes in Shareholders' Equity and of Cash Flows for the three months ended March 31, 2026 and 2025 are unaudited. The Consolidated Balance Sheet as of December 31, 2025 was derived from the Audited Consolidated Financial Statements as of that date. The interim Consolidated Financial Statements and the accompanying notes should be read in conjunction with the annual Consolidated Financial Statements and the accompanying notes contained within the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as filed with the SEC. In the opinion of management, the Company's Consolidated Financial Statements reflect all adjustments, which include only normal recurring adjustments, necessary for a fair statement of the results of operations for the periods presented. The results for the three months ended March 31, 2026 are not necessarily indicative of results to be expected for the year ending December 31, 2026, any other interim period, or any future year or period.

The Company qualifies as an emerging growth company ("EGC") under the Jumpstart Our Business Startups Act of 2012 and has the ability to defer the adoption of new or revised accounting standards until the nonpublic company effective dates. As such, the Company will adopt standards on the nonpublic company effective dates until such time that we no longer qualify as an EGC.

Subsequent events are events or transactions that occur after the balance sheet date but before consolidated financial statements are issued. Recognized subsequent events are events or transactions that provide additional evidence about conditions that existed at the date of the consolidated balance sheet, including the estimates inherent in the process of preparing consolidated financial statements. Non-recognized subsequent events are events that provide evidence about conditions that did not exist at the date of the consolidated balance sheet but arose after that date.

***Provident Bancorp, Inc. and BankProv Acquisition***

On November 15, 2025, the Company completed its acquisition of Provident Bancorp, Inc. and BankProv ("Provident"). The total consideration paid in the acquisition of Provident was $111.8 million in cash and the issuance of 5,943,682 shares of common stock valued at $114.7 million. The acquisition added $1.40 billion of total assets, $1.23 billion of total loans and $1.14 billion in total deposits, each at fair value, as of the date of closing.

The acquisition was accounted for under the acquisition method of accounting in accordance with ASC Topic 805, *Business Combinations*. Under this method of accounting, the respective assets acquired and liabilities assumed were recorded at their estimated fair values. The excess of consideration paid over the estimated fair value of the net assets acquired totaled $18.5 million and was recorded as goodwill. The results of Provident's operations were included in the Company's consolidated financial statements beginning on November 15, 2025.

The calculation of goodwill is subject to change for up to one year after the closing date of the transaction as additional information relative to closing date estimated and uncertainties becomes available. The Company made no adjustments to Goodwill during the three months ended March 31, 2026.

***Operating Segments***

Reportable segments are those revenue producing components for which separate financial information is produced internally and which are subject to evaluation by the chief operating decision maker ("CODM"). The Company has determined that its CODM is its Chief Executive Officer. The Company has one reportable segment: its banking business, which consists of a full range of banking lending, savings, and small business offerings. The CODM regularly assesses performance of the aggregated single operating and reporting segment and decides how to allocate resources based on net income calculated on the same basis as net income reported in the Company's consolidated statements of income and other comprehensive income. The CODM is also regularly provided with expense information at a level consistent with that disclosed in the Company's consolidated statements of income and other comprehensive income.

[**Table of Contents**](#TOC)

#### Note 2 – Summary of Significant Accounting Policies
***Use of Estimates***

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses. Actual results could differ from those estimates.

Material estimates that are particularly susceptible to significant change in the near term relate to the determination of the Allowance for Credit Losses ("ACL") on loans, fair value determination of acquired assets and liabilities and resulting accretion and amortization of purchase accounting premiums/discounts, the valuation of real estate acquired in connection with foreclosures or in satisfaction of loans, the valuation of deferred tax assets, actuarial estimates related to the Company's retirement programs, the valuation of financial instruments and impairment of goodwill and other intangibles. In connection with the determination of the ACL and foreclosed real estate, management obtains independent appraisals for significant properties.

A majority of the Company's loan portfolio consists of one-to-four-family residential, commercial real estate and construction and land development loans in the metro-west area of Boston and its surrounding communities. Accordingly, the ultimate collectability of a substantial portion of the Company's loan portfolio and the recovery of the carrying amount of foreclosed real estate are susceptible to changes in local market conditions.

While management uses currently available information to recognize losses on loans and foreclosed real estate, future additions to the ACL and valuation reserves on foreclosed real estate may be necessary based on changes in local economic conditions. In addition, regulatory agencies, as an integral part of their examination process, periodically review the Company's ACL on loans and valuation reserves on foreclosed real estate. Such agencies may require the Company to recognize additions to the ACL on loans and valuation reserves on foreclosed real estate based on their judgments about information available to them at the time of their examination. Because of these factors, it is reasonably possible that the ACL on loans and valuation reserves on foreclosed real estate may change in the near future.

**Business Combinations** – Acquisitions of businesses are accounted for using the acquisition method of accounting. In accordance with applicable accounting guidance, we recognize assets acquired and liabilities assumed at their respective fair values as of the date of acquisition, with the related transaction costs expensed in the period incurred. We use third party valuation specialists to assist in the determination of fair value of certain assets and liabilities at the merger date, including loans and core deposit intangibles. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed on the acquisition date, the estimates are inherently uncertain.

For further discussion of our methodology for estimating the fair value of acquired assets and assumed liabilities in connection with our Provident Acquisition, see *Note 1 – Corporate Structure and Nature of Operations; Basis of Presentation – Provident Bancorp, Inc. and BankProv Acquisition*.

***Recent Accounting Pronouncements***

*Relevant standards that were recently issued but not yet adopted as of March 31, 2026:*

In November 2024, the FASB issued ASU 2024-03, "Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Sub Topic 220-40): Disaggregation of Income Statement Expenses". ASU 2024-03 improves disclosures about a public business entity's expenses and addresses requests from investors for more detailed information about the types of expenses (including purchases of inventory, employee compensation, depreciation, amortization, and depletion) in commonly presented expense captions (such as cost of sales, SG&A, and research and development). ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The adoption of ASU 2024-03 is not expected to have a material impact on the Company's consolidated financial statements.

[**Table of Contents**](#TOC)

Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies are not expected to have a material impact on the Company's financial position, results of operations or cash flows.

#### Note 3 – Securities
The Company's available-for-sale ("AFS") securities are carried at fair value. For AFS securities in an unrealized loss position, management will first evaluate whether there is intent to sell, or if it is more likely than not that the Company will be required to sell a security prior to anticipated recovery of its amortized cost basis. If either of these criteria are met, the Company will record a write-down of the security's amortized cost basis to fair value through income. For those AFS securities which do not meet the intent or requirement to sell criteria, management will evaluate whether the decline in fair value is a result of credit related matters or other factors.

In performing this assessment, management considers the creditworthiness of the issuer including whether the security is guaranteed by the U.S. Federal Government or other government agency, the extent to which fair value is less than amortized cost, and changes in credit rating during the period, among other factors. If this assessment indicates the existence of credit losses, the security will be written down to fair value, as determined by a discounted cash flow analysis. To the extent the estimated cash flows do not support the amortized cost, the deficiency is considered to be due to credit loss and is recognized in earnings.

Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense. Losses are charged against the allowance when the uncollectibility of a security is confirmed, or when either of the aforementioned criteria surrounding intent or requirement to sell have been met.

Securities have been classified on the consolidated balance sheets according to management's intent.

The following tables summarize the amortized cost, allowance for credit losses, and fair value of securities and their corresponding amounts of unrealized gains and losses at the dates indicated:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Amortized**<br>**Cost** | **Unrealized**<br>**Gain** | **Unrealized**<br>**Loss** | **Allowance for**<br>**Credit Losses** | <br>**Fair Value** |
| <br>**March 31, 2026** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Available-for-Sale Debt Securities: |  |  |  |  |  |
| &nbsp;&nbsp;U.S. Treasury securities | $96467 | $132 | $(278) | $— | $96321 |
| &nbsp;&nbsp;U.S. Government agencies | 4670 | 20 | (4) |  | 4686 |
| &nbsp;&nbsp;Agency mortgage-backed securities | 91838 | 100 | (2085) |  | 89853 |
| &nbsp;&nbsp;Agency collateralized mortgage obligations | 11321 | 191 | (125) |  | 11387 |
| &nbsp;&nbsp;Corporate bonds | 64702 | 271 | (2976) |  | 61997 |
| &nbsp;&nbsp;Municipal obligations | 6599 |  | (59) |  | 6540 |
| &nbsp;&nbsp;SBA securities | 6574 |  | (117) |  | 6457 |
| Total | $282171 | $714 | $(5644) | $— | $277241 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Amortized**<br>**Cost** | **Unrealized**<br>**Gain** | **Unrealized**<br>**Loss** | **Allowance for**<br>**Credit Losses** | <br>**Fair Value** |
| <br>**December 31, 2025** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Available-for-Sale Debt Securities: |  |  |  |  |  |
| &nbsp;&nbsp;U.S. Treasury securities | $95479 | $407 | $(103) | $— | $95783 |
| &nbsp;&nbsp;U.S. Government agencies | 9159 | 53 |  |  | 9212 |
| &nbsp;&nbsp;Agency mortgage-backed securities | 69682 | 162 | (1253) |  | 68591 |
| &nbsp;&nbsp;Agency collateralized mortgage obligations | 12109 | 202 | (74) |  | 12237 |
| &nbsp;&nbsp;Corporate bonds | 72703 | 263 | (3081) |  | 69885 |
| &nbsp;&nbsp;Municipal obligations | 6596 |  | (72) |  | 6524 |
| &nbsp;&nbsp;SBA securities | 6830 |  | (103) |  | 6727 |
| Total | $272558 | $1087 | $(4686) | $— | $268959 |

---

[**Table of Contents**](#TOC)

The Company did not record a provision for estimated credit losses on any AFS securities for the three months ended March 31, 2026 and 2025. Excluded from the table above is accrued interest on AFS securities of $2.1 million and $1.8 million at March 31, 2026 and December 31, 2025, respectively, which is included within accrued interest receivable on the consolidated balance sheets. Additionally, the Company did not record any write-offs of accrued interest income on AFS securities for the three months ended March 31, 2026 and 2025. No securities held by the Company were delinquent on contractual payments at March 31, 2026 or December 31, 2025, nor were any securities placed on non-accrual status during the three months ended March 31, 2026 and 2025.

The following is a summary of actual maturities of certain AFS securities as of March 31, 2026. The amortized cost and fair values are based on the contractual maturity dates. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalty.

Agency mortgage-backed securities and collateralized mortgage obligations are presented as separate lines as paydowns are expected to occur before contractual maturity dates.

---

| | | |
|:---|:---|:---|
|  | **Available-for-Sale** | **Available-for-Sale** |
|  | **Amortized Cost** | **Fair Value** |
|  | **(in thousands)** | **(in thousands)** |
| Within one year | $66586 | $66344 |
| Over one year to five years | 68355 | 68092 |
| Over five years to ten years | 39940 | 37557 |
| Over ten years | 4131 | 4008 |
|  | 179012 | 176001 |
| Agency mortgage-backed securities | 91838 | 89853 |
| Agency collateralized mortgage obligations | 11321 | 11387 |
|  | $282171 | $277241 |

---

When securities are sold, the adjusted cost of the specific security sold is used to compute the gain or loss on the sale. There were no sales of AFS securities during the three months ended March 31, 2026 and 2025.

The carrying value of AFS securities pledged to secure advances from the FHLB were $216.4 million and $111.5 million as of March 31, 2026 and December 31, 2025, respectively.

The following tables present fair value and gross unrealized losses, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position, as of the dates stated.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **Less than 12 Months** | **Less than 12 Months** | **12 Months or More** | **12 Months or More** | **Total** | **Total** |
| | | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** |
| | | **Gross** |  | **Gross** |  | **Gross** |  |
| | | **Unrealized**  | **Fair** | **Unrealized**  | **Fair** | **Unrealized**  | **Fair** |
| <br>**March 31, 2026** | <br>**Number of Securities** | **Losses** | **Value** | **Losses** | **Value** | **Losses** | **Value** |
| U.S. Treasuries | 24 | $(207) | $46177 | $(71) | $2930 | $(278) | $49107 |
| U.S. Government Agencies | 1 | (4) | 1621 |  |  | (4) | 1621 |
| Agency mortgage-backed securities | 36 | (882) | 48968 | (1203) | 31175 | (2085) | 80143 |
| Agency collateralized mortgage obligations | 4 | (7) | 1958 | (118) | 6897 | (125) | 8855 |
| Corporate bonds | 20 | (459) | 7533 | (2517) | 42741 | (2976) | 50274 |
| Municipal obligations | 6 |  |  | (59) | 6540 | (59) | 6540 |
| SBA securities | 5 | (6) | 956 | (111) | 5501 | (117) | 6457 |
| Total | 96 | $(1565) | $107213 | $(4079) | $95784 | $(5644) | $202997 |

---

[**Table of Contents**](#TOC)

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **Less than 12 Months** | **Less than 12 Months** | **12 Months or More** | **12 Months or More** | **Total** | **Total** |
| | | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** |
| | | **Gross** |  | **Gross** |  | **Gross** |  |
| | | **Unrealized**  | **Fair** | **Unrealized**  | **Fair** | **Unrealized**  | **Fair** |
| <br>**December 31, 2025** | <br>**Number of Securities** | **Losses** | **Value** | **Losses** | **Value** | **Losses** | **Value** |
| U.S. Treasury securities | 8 | $(11) | $8929 | $(92) | $10945 | $(103) | $19874 |
| Agency mortgage-backed securities | 25 | (301) | 26876 | (952) | 31890 | (1253) | 58766 |
| Agency collateralized mortgage obligations | 4 | (7) | 1995 | (67) | 7324 | (74) | 9319 |
| Corporate bonds | 24 | (356) | 6634 | (2725) | 53538 | (3081) | 60172 |
| Municipal obligations | 6 | (1) | 1440 | (71) | 5084 | (72) | 6524 |
| SBA securities | 5 | (28) | 2299 | (75) | 4428 | (103) | 6727 |
| Total | 72 | $(704) | $48173 | $(3982) | $113209 | $(4686) | $161382 |

---

Management evaluates securities for expected credit losses at least on a quarterly basis, and more frequently when economic or market concerns warrant such evaluation.

Included in corporate bonds are investments in senior and subordinated debt of banks and bank holding companies, some of which do not have investment ratings.

At March 31, 2026, AFS debt securities had unrealized losses with aggregate depreciation of 2.7% from the Company's amortized cost basis. These unrealized losses relate to changes in market interest rates since acquiring the securities. As management has the intent and ability to hold these securities until maturity or cost recovery, no allowance for credit losses on securities is deemed necessary as of March 31, 2026 and December 31, 2025.

#### Note 4 – Loans Receivable, Allowance for Credit Losses and Credit Quality
**Loans Held for Sale**

Loans held for sale to the secondary market are carried at the lower of cost or estimated market value on an individual loan basis. Gains on sales of loans are recognized in the consolidated statements of income at the time of sale. Losses on sales of loans are recognized in the consolidated statements of income when incurred. Interest income is recognized on loans held for sale between the time the loan is funded and the loan is sold. Direct loan origination costs and fees are deferred upon origination and are recognized in the consolidated statements of income on the date of sale. As of March 31, 2026 and December 31, 2025, the Company had $64.0 million and $66.4 million of consumer loans held for sale, respectively.

**Loans Receivable**

Loans that management has the intent and ability to hold for the foreseeable future or until maturity or pay-off are reported as held for investment at their outstanding principal balance adjusted for any charge-offs and net of any deferred fees (including purchase accounting adjustments) and origination costs (collectively referred to as "amortized cost"). Loan origination fees and certain direct origination costs are deferred and amortized as an adjustment of yield using the payment terms required by the loan contract. When loans are sold or repaid, any unamortized fees and costs are recorded to interest income on loans. Interest income on loans is accrued based upon the daily principal amount outstanding except for loans on non-accrual status. For acquired loans with no signs of credit deterioration at acquisition, interest income is also accrued based upon the daily principal amount outstanding, adjusted further by the accretion of any discount or amortization of any premium associated with the loan.

Loans are generally placed into nonaccrual status when they are past due 90 days or more as to either principal or interest or when, in the opinion of management, the collection of principal and/or interest is in doubt. A loan remains in nonaccrual status until the loan is current as to payment of both principal and interest or past due less than 90 days and the borrower demonstrates the ability to pay and remain current. When cash payments are received, they are applied to principal first, then to accrued interest. It is the Company's policy not to record interest income on nonaccrual loans until principal has become current. In certain instances, accruing loans that are past due 90 days or more as to principal or interest may not go on nonaccrual status if the Company determines that the loans are well-secured and are in the process of collection.

[**Table of Contents**](#TOC)

**Allowance for Credit Losses**

The ACL represents management's best estimate of credit losses over the remaining life of the loan portfolio. Loans are charged-off against the ACL when management believes the loan balance is no longer collectible. Subsequent recoveries of previously charged-off amounts are recorded as increases to the ACL. The provision for credit losses is an amount sufficient to bring the ACL to an estimated balance that management considers adequate to absorb lifetime expected losses in the Company's held-for-investment loan portfolio. The ACL is a valuation account that is deducted from the loans' amortized cost basis to present the net amount expected to be collected on the loans.

Management's determination of the adequacy of the ACL under FASB ASC 326 is based on an evaluation of the composition of the loan portfolio, current economic conditions, historical loan loss experience, reasonable and supportable forecasts, and other risk factors. The Company uses a third-party CECL model as part of its estimation of the ACL on a quarterly basis. Loans with similar risk characteristics are collectively assessed within pools (or segments). Loss estimates within the collectively assessed population are based on a combination of pooled assumptions and loan-level characteristics. The Company has determined that using federal call codes is an appropriate loan segmentation methodology, as it is generally based on risk characteristics of a loan's underlying collateral.

Using federal call codes also allows the Company to utilize and assess publicly available external information when developing its estimate of the ACL. The weighted average remaining maturity ("WARM") method is the primary credit loss estimation methodology used by the Company and involves estimating future cash flows and expected credit losses for pools of loans using their expected remaining WARM.

In applying future economic forecasts, the Company utilizes a forecast period of up to two years. The Company considers economic forecasts of inflation, national gross domestic product, and unemployment rates sourced from the Federal Open Market Committee's "Summary of Economic Projections" to inform the model for future loss estimation.

Additionally, interest rate forecasts sourced from CME Group's "FedWatch", Wells Fargo's "U.S. Economic Outlook," and FHN Financial's "Economic Forecast" publications are used for consideration of rate sensitivity in the model's loan prepayment speed estimation. Historical loss rates used in the quantitative model are primarily derived using both the Bank's data and peer bank data obtained from publicly available sources (i.e., federal call reports). The Bank's peer group is comprised of financial institutions of relatively similar size and in similar markets (i.e., $10 billion or less of total assets and headquartered in New England). The peer group used for certain loan segments is a national peer group of financial institutions of relatively similar size, where appropriate. The changes did not have a material impact on the ACL during the year ended December 31, 2025.

Management also considers qualitative adjustments when estimating credit losses to take into account the model's quantitative limitations.

Management continually assesses the peer group and related data used to inform the ACL calculation.

Qualitative adjustments to quantitative loss factors, either negative or positive, may include considerations of economic conditions including economic forecasts as detailed above, volume and severity of past due loans, value of underlying collateral, experience, depth, and ability of management, and concentrations of credit.

The Company made no significant changes to loss factors, assumptions nor qualitative factors within the CECL model during the three months ended March 31, 2026 and 2025.

For those loans that do not share similar risk characteristics, the Company evaluates the ACL needs on an individual (or loan by loan) basis. This population of individually evaluated loans (or loan relationships with the same primary source of repayment) is determined on a quarterly basis and consists of: loans with a risk rating of substandard or worse or loan terms differing significantly from other pooled loans. In accordance with the Company's policy, non-accrual residential real estate loans that are below $500,000 and well secured (loan-to-value <60%) are excluded from being individually evaluated.

[**Table of Contents**](#TOC)

Measurement of credit loss is based on the expected future cash flows of an individually evaluated loan, discounted at the loan's effective interest rate, or measured on an observable market value, if one exists, or the estimated market value of the collateral underlying the loan, discounted to consider estimated costs to sell the collateral for collateral-dependent loans. If the net value is less than the loan's amortized cost, a specific reserve in the ACL is recorded, which is charged-off in the period when management believes the loan balance is no longer collectible.

The Company's Troubled Asset Resolution Committee approves the key methodologies and assumptions, as well as the ACL on at least a quarterly basis. While management uses available information at the time of estimation to determine expected credit losses on loans, future changes in the ACL may be necessary based on changes in portfolio composition, portfolio credit quality, and/or economic conditions. In addition, bank regulatory agencies periodically review the Bank's ACL and may require an increase in the provision for credit losses or the recognition of further loan charge-offs, based on judgments different than those of management.

**Collateral-dependent Loans –** The Company has certain loans for which repayment is dependent upon the operation or sale of collateral, as the borrower is experiencing financial difficulty. The underlying collateral can vary based upon the type of loan. The following provides more detail about the types of collateral that secure collateral-dependent loans:

● Commercial real estate and multifamily loans may be secured by either owner-occupied commercial real estate or non-owner-occupied investment commercial real estate. Typically, owner-occupied commercial real estate loans are secured by office buildings, warehouses, manufacturing facilities, and other commercial and industrial properties occupied by operating companies. Repayment is generally from the cash flows of the business occupying the property.

Non-owner-occupied commercial real estate loans are generally secured by office buildings and complexes, retail facilities, multifamily complexes, land under development, industrial properties, as well as other commercial or industrial real estate.

● Commercial and industrial loans may be secured by non-real estate collateral such as accounts receivable, inventory, equipment, or other similar assets. Enterprise value is defined as imputed value for the entire underlying business. To determine an appropriate range of enterprise value, management relies on a standardized set of valuation methodologies that take into account future projected cash flows, market-based multiples, as well as asset values. Valuations involve both quantitative and qualitative considerations and professional judgments concerning differences in financial and operating characteristics in addition to other factors that may impact values over time.

● Residential real estate loans are typically secured by first mortgages, and in some cases could be secured by a second mortgage.

● Home equity lines of credit are generally secured by second mortgages on residential real estate property.

● Consumer loans are generally secured by boat and recreational vehicles, automobiles, solar panels and other personal property. Some consumer loans are unsecured, have no underlying collateral, and would not be considered collateral-dependent.

● Warehouse loans are primarily facility lines to non-bank mortgage origination companies. The underlying collateral of these loans are residential real estate loans.

**Purchased Credit-Deteriorated ("PCD") Loans -** PCD loans are acquired individual loans (or acquired groups of loans with similar risk characteristics) that, as of the date of acquisition, have experienced a more-than-insignificant deterioration in credit quality, as determined by the Company's analyses. A PCD loan is recorded at its purchase price plus the ACL expected at the time of acquisition, or "gross up" of the amortized cost basis, if any. Changes in the current estimate of the ACL subsequent to acquisition from the estimated allowance previously recorded are recognized in the income statement as provision for credit losses or recoveries of credit losses in subsequent periods as they arise.

[**Table of Contents**](#TOC)

Evidence that purchased loans, measured at amortized cost, have more-than-insignificant deterioration in credit quality and, therefore meet the PCD definition, may include past-due status, non-accrual status, risk rating and other standard indicators (i.e., modification due to financial difficulty, charge-offs, bankruptcy).

In the ordinary course of business, the Company enters into commitments to extend credit. Such financial instruments are recorded in the consolidated financial statements when they are funded. The credit risk associated with these commitments is evaluated in a manner similar to the ACL on loans. The reserve for unfunded commitments is included in other liabilities on the consolidated balance sheets.

Loans consist of the following as of the dates stated:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** |
|  | **Amount** | **Percent** | **Amount** | **Percent** |
|  | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** |
| One-to-four-family residential | $1185601 | 19.06% | $1177156 | 19.64% |
| Home equity | 155717 | 2.50% | 152602 | 2.55% |
| &nbsp;&nbsp;Total residential real estate | 1341318 | 21.56% | 1329758 | 22.19% |
| Commercial real estate | 1924862 | 30.95% | 1924043 | 32.09% |
| Multi-family residential | 538164 | 8.65% | 517527 | 8.63% |
| &nbsp;&nbsp;Total commercial real estate | 2463026 | 39.60% | 2441570 | 40.72% |
| Construction and land development | 782721 | 12.58% | 730573 | 12.19% |
| Commercial and industrial | 1143086 | 18.38% | 1007669 | 16.81% |
| &nbsp;&nbsp;Total commercial | 4388833 | 70.56% | 4179812 | 69.72% |
| Consumer, net of premium/discount | 212923 | 3.42% | 203497 | 3.40% |
| Mortgage warehouse | 277191 | 4.46% | 280949 | 4.69% |
| &nbsp;&nbsp;Total loans | 6220265 | 100.00% | 5994016 | 100.00% |
| Deferred fees, net | (10355) |  | (7876) |  |
| Allowance for credit losses | (80195) |  | (87411) |  |
| &nbsp;&nbsp;Net loans | $6129715 |  | $5898729 |  |

---

Included in the above are approximately $466.8 million and $404.8 million in loans to borrowers in the cannabis industry at March 31, 2026 and December 31, 2025, respectively. Of that total, $321.0 million and $228.8 million were direct loans to cannabis companies and were collateralized by real estate at March 31, 2026 and December 31, 2025, respectively.

During the three months ended March 31, 2026 and 2025, the Company purchased approximately $14.7 million and $14.4 million of consumer loan pools, respectively. The loans purchased during the three months ended March 31, 2026 and 2025 included loan pools collateralized by automobiles.

The outstanding balances of consumer purchased loans, shown net of premium (discount) are as follows as of the dates stated:

---

| | | | |
|:---|:---|:---|:---|
|  | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** |
|  | **Gross Loan** | **Premium (Discount)** | **Net Loan** |
|  | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Student loans | $4993 | $36 | $5029 |
| Automobile loans | 82167 |  | 82167 |
| Solar panel loans | 47364 | (4284) | 43080 |
| Home improvement loans | 34108 | (24) | 34084 |
| &nbsp;&nbsp;Total | $168632 | $(4272) | $164360 |

---

[**Table of Contents**](#TOC)

---

| | | | |
|:---|:---|:---|:---|
|  | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
|  | **Gross Loan** | **Premium (Discount)** | **Net Loan** |
|  | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Student loans | $5421 | $34 | $5455 |
| Boat and RV loans | 238 |  | 238 |
| Automobile loans | 75560 |  | 75560 |
| Solar panel loans | 49077 | (4667) | 44410 |
| Home improvement loans | 35845 | (13) | 35832 |
| &nbsp;&nbsp;Total | $166141 | $(4646) | $161495 |

---

The carrying value of loans pledged to secure advances from the FHLB were $1.25 billion and $1.56 billion as of March 31, 2026 and December 31, 2025, respectively.

The following table presents the aging of the amortized cost of loans receivable by loan category as of the date stated:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** |
|  | <br>**Current**<br>**Loans** | **30-59**<br> **Days**<br>**Past Due** | **60-89**<br>**Days**<br>**Past Due** | **90 Days or**<br>**More Past Due**<br>**Still Accruing** | <br>**Nonaccrual** | <br>**Total**<br> **Loans** |
|  | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Real estate loans: |  |  |  |  |  |  |
| &nbsp;&nbsp;One-to-four-family residential | $1178542 | $5225 | $71 | $— | $1763 | $1185601 |
| &nbsp;&nbsp;Home equity | 153511 | 533 |  |  | 1673 | 155717 |
| &nbsp;&nbsp;Commercial real estate | 1911674 | 60 | 80 | 12654 | 394 | 1924862 |
| &nbsp;&nbsp;Multi-family residential | 538164 |  |  |  |  | 538164 |
| &nbsp;&nbsp;Construction and land development | 782711 |  |  |  | 10 | 782721 |
| Commercial and industrial | 1102974 | 351 | 876 |  | 38885 | 1143086 |
| Consumer | 204088 | 4407 | 1590 |  | 2838 | 212923 |
| Mortgage warehouse | 277191 |  |  |  |  | 277191 |
| &nbsp;&nbsp;Total | $6148855 | $10576 | $2617 | $12654 | $45563 | $6220265 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
|  | <br>**Current**<br>**Loans** | **30-59**<br> **Days**<br>**Past Due** | **60-89**<br>**Days**<br>**Past Due** | **90 Days or**<br>**More Past Due**<br>**Still Accruing** | <br>**Nonaccrual** | <br>**Total**<br> **Loans** |
|  | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Real estate loans: |  |  |  |  |  |  |
| &nbsp;&nbsp;One-to-four-family residential | $1166731 | $7232 | $481 | $— | $2712 | $1177156 |
| &nbsp;&nbsp;Home equity | 150413 | 445 | 385 |  | 1359 | 152602 |
| &nbsp;&nbsp;Commercial real estate | 1923108 | 80 |  |  | 855 | 1924043 |
| &nbsp;&nbsp;Multi-family residential | 517527 |  |  |  |  | 517527 |
| &nbsp;&nbsp;Construction and land development | 730563 |  |  |  | 10 | 730573 |
| Commercial and industrial | 895662 | 73225 | 2531 |  | 36251 | 1007669 |
| Consumer | 194595 | 4665 | 2022 |  | 2215 | 203497 |
| Mortgage Warehouse | 280949 |  |  |  |  | 280949 |
| &nbsp;&nbsp;Total | $5859548 | $85647 | $5419 | $— | $43402 | $5994016 |

---

As of March 31, 2026, the Company had one commercial and industrial loan with an outstanding balance of $12.7 million that was ninety days past due and still accruing. The loan is well secured and in the process of collection, as the borrower has brought the loan current. The Company had no loans ninety days past due and still accruing as of March 31, 2025.

[**Table of Contents**](#TOC)

The following table presents the amortized cost of nonaccrual loans receivable by loan category as of the dates stated:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
|  | **Nonaccrual**<br> **Loans with**<br> **No ACL** | **Nonaccrual**<br> **Loans with**<br> **an ACL** | **Total** <br>**Nonaccrual**<br> **Loans** | **Nonaccrual**<br> **Loans with**<br> **No ACL** | **Nonaccrual**<br> **Loans with**<br> **an ACL** | **Total** <br>**Nonaccrual**<br> **Loans** |
|  | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** |
| Real estate loans: |  |  |  |  |  |  |
| &nbsp;&nbsp;One-to-four-family residential | $1763 | $— | $1763 | $2712 | $— | $2712 |
| &nbsp;&nbsp;Home equity | 1673 |  | 1673 | 1359 |  | 1359 |
| &nbsp;&nbsp;Commercial real estate | 394 |  | 394 | 855 |  | 855 |
| &nbsp;&nbsp;Construction and land development | 10 |  | 10 | 10 |  | 10 |
| Commercial and industrial | 18421 | 20464 | 38885 | 19799 | 16452 | 36251 |
| Consumer | 2838 |  | 2838 | 2215 |  | 2215 |
| &nbsp;&nbsp;Total | $25099 | $20464 | $45563 | $26950 | $16452 | $43402 |

---

During the three months ended March 31, 2026 and 2025, the Company reversed $483,000 and $378,000 of interest income for loans that were placed on non-accrual respectively.

Credit Quality Information

The Company utilizes a nine-grade internal rating system for all loans, except consumer loans, which are not risk rated, as follows:

Loans rated 1-5: Loans in these categories are considered "pass" rated loans with low to average risk.

Loans rated 6: Loans in this category are considered "special mention". These loans are starting to show signs of potential weakness and are being closely monitored by management.

Loans rated 7: Loans in this category are considered "substandard". Generally, a loan is considered substandard if it is inadequately protected by the current net worth and paying capacity of the obligors and/or the collateral pledged. There is a distinct possibility that the Company will sustain some loss if the weakness is not corrected. Non-accrual residential real estate and commercial loans are downgraded to a substandard risk rating.

Loans rated 8: Loans in this category are considered "doubtful". Loans classified as doubtful have all the weaknesses inherent in those classified as substandard with the added characteristic that the weaknesses make collection or liquidation in full, on the basis of currently existing facts, highly questionable and improbable.

Loans rated 9: Loans in this category are considered uncollectible ("loss") and of such little value that their continuance as loans is not warranted.

On an annual basis, or more often if needed, the Company reviews the accuracy of risk ratings for all commercial real estate, construction and land development loans, and commercial and industrial loans based on various ongoing performance characteristics and supporting information that is provided from time to time by commercial borrowers. Annually, the Company engages an independent third-party to review a significant portion of loans within these segments. Management uses the results of these reviews as part of its annual review process.

[**Table of Contents**](#TOC)

The following table presents the amortized cost of loans receivable by internal risk grade by year of origination as of March 31, 2026. Also presented are current period gross charge-offs by loan type and vintage year for the three months ended March 31, 2026:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** |
|  | <br>**Risk Rating** | **2026** | **2025** | **2024** | **2023** | **2022** | **Prior** | **Revolving Loans** | **Total** |
| **One-to-Four-Family Residential** |  |  |  |  |  |  |  |  |  |
| Grade: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 1-5 | $34044 | $111535 | $91410 | $128377 | $249884 | $531121 | $37309 | $1183680 |
| &nbsp;&nbsp;&nbsp;Special Mention | 6 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Substandard | 7 |  |  |  |  |  | 1793 | 128 | 1921 |
| &nbsp;&nbsp;&nbsp;Doubtful | 8 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loss | 9 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loans not formally risk rated <sup>(1)</sup> |  |  |  |  |  |  |  |  |  |
| Total |  | $34044 | $111535 | $91410 | $128377 | $249884 | $532914 | $37437 | $1185601 |
| Current period gross charge-offs |  | $— | $— | $— | $— | $— | $56 | $— | $56 |
| **Home Equity** |  |  |  |  |  |  |  |  |  |
| Grade: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 1-5 | $— | $— | $494 | $245 | $— | $761 | $152543 | $154043 |
| &nbsp;&nbsp;&nbsp;Special Mention | 6 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Substandard | 7 |  |  | 62 | 125 |  | 450 | 1037 | 1674 |
| &nbsp;&nbsp;&nbsp;Doubtful | 8 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loss | 9 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loans not formally risk rated <sup>(1)</sup> |  |  |  |  |  |  |  |  |  |
| Total |  | $— | $— | $556 | $370 | $— | $1211 | $153580 | $155717 |
| Current period gross charge-offs |  | $— | $— | $— | $— | $— | $— | $— | $— |
| **Commercial Real Estate** |  |  |  |  |  |  |  |  |  |
| Grade: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 1-5 | $38914 | $315912 | $163071 | $270371 | $340981 | $597223 | $72775 | $1799247 |
| &nbsp;&nbsp;&nbsp;Special Mention | 6 |  |  | 13395 | 33569 | 48800 | 6561 |  | 102325 |
| &nbsp;&nbsp;&nbsp;Substandard | 7 |  |  |  |  |  | 23290 |  | 23290 |
| &nbsp;&nbsp;&nbsp;Doubtful | 8 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loss | 9 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loans not formally risk rated <sup>(1)</sup> |  |  |  |  |  |  |  |  |  |
| Total |  | $38914 | $315912 | $176466 | $303940 | $389781 | $627074 | $72775 | $1924862 |
| Current period gross charge-offs |  | $— | $— | $— | $— | $— | $— | $— | $— |
| **Multi-Family** |  |  |  |  |  |  |  |  |  |
| Grade: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 1-5 | $21015 | $52911 | $17020 | $78387 | $231887 | $135286 | $1658 | $538164 |
| &nbsp;&nbsp;&nbsp;Special Mention | 6 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Substandard | 7 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Doubtful | 8 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loss | 9 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loans not formally risk rated <sup>(1)</sup> |  |  |  |  |  |  |  |  |  |
| Total |  | $21015 | $52911 | $17020 | $78387 | $231887 | $135286 | $1658 | $538164 |
| Current period gross charge-offs |  | $— | $— | $— | $— | $— | $— | $— | $— |
| **Construction and Land Development** |  |  |  |  |  |  |  |  |  |
| Grade: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 1-5 | $36390 | $107159 | $212312 | $252742 | $12750 | $19579 | $122141 | $763073 |
| &nbsp;&nbsp;&nbsp;Special Mention | 6 |  |  |  |  | 19638 |  |  | 19638 |
| &nbsp;&nbsp;&nbsp;Substandard | 7 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Doubtful | 8 |  |  |  |  |  | 10 |  | 10 |
| &nbsp;&nbsp;&nbsp;Loss | 9 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loans not formally risk rated <sup>(1)</sup> |  |  |  |  |  |  |  |  |  |
| Total |  | $36390 | $107159 | $212312 | $252742 | $32388 | $19589 | $122141 | $782721 |
| Current period gross charge-offs |  | $— | $— | $— | $— | $— | $— | $— | $— |
| **Commercial and Industrial** |  |  |  |  |  |  |  |  |  |
| Grade: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 1-5 | $200953 | $85481 | $64217 | $100716 | $75819 | $145284 | $291815 | $964285 |
| &nbsp;&nbsp;&nbsp;Special Mention | 6 |  | 13628 | 465 | 1156 | 9034 | 10823 | 94719 | 129825 |
| &nbsp;&nbsp;&nbsp;Substandard | 7 |  | 9500 |  | 3519 | 16183 | 13403 | 6362 | 48967 |
| &nbsp;&nbsp;&nbsp;Doubtful | 8 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loss | 9 |  |  |  |  | 9 |  |  | 9 |
| &nbsp;&nbsp;&nbsp;Loans not formally risk rated <sup>(1)</sup> |  |  |  |  |  |  |  |  |  |
| Total |  | $200953 | $108609 | $64682 | $105391 | $101045 | $169510 | $392896 | $1143086 |
| Current period gross charge-offs |  | $— | $— | $— | $— | $7072 | $5298 | $— | $12370 |

---

[**Table of Contents**](#TOC)

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** |
|  | <br>**Risk Rating** | **2026** | **2025** | **2024** | **2023** | **2022** | **Prior** | **Revolving Loans** | **Total** |
| **Consumer** |  |  |  |  |  |  |  |  |  |
| Grade: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 1-5 | $— | $— | $— | $— | $— | $— | $— | $— |
| &nbsp;&nbsp;&nbsp;Special Mention | 6 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Substandard | 7 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Doubtful | 8 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loss | 9 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loans not formally risk rated <sup>(1)</sup> |  | 14814 | 57344 | 36789 | 3615 | 38833 | 56483 | 5045 | 212923 |
| Total |  | $14814 | $57344 | $36789 | $3615 | $38833 | $56483 | $5045 | $212923 |
| Current period gross charge-offs |  | $— | $— | $164 | $91 | $496 | $651 | $7 | $1409 |
| **Mortgage Warehouse** |  |  |  |  |  |  |  |  |  |
| Grade: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 1-5 | $— | $— | $— | $— | $— | $— | $277191 | $277191 |
| &nbsp;&nbsp;&nbsp;Special Mention | 6 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Substandard | 7 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Doubtful | 8 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loss | 9 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loans not formally risk rated <sup>(1)</sup> |  |  |  |  |  |  |  |  |  |
| Total |  | $— | $— | $— | $— | $— | $— | $277191 | $277191 |
| Current period gross charge-offs |  | $— | $— | $— | $— | $— | $— | $— | $— |
| **Total Loans** |  |  |  |  |  |  |  |  |  |
| Grade: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 1-5 | $331316 | $672998 | $548524 | $830838 | $911321 | $1429254 | $955432 | $5679683 |
| &nbsp;&nbsp;&nbsp;Special Mention | 6 |  | 13628 | 13860 | 34725 | 77472 | 17384 | 94719 | 251788 |
| &nbsp;&nbsp;&nbsp;Substandard | 7 |  | 9500 | 62 | 3644 | 16183 | 38936 | 7527 | 75852 |
| &nbsp;&nbsp;&nbsp;Doubtful | 8 |  |  |  |  |  | 10 |  | 10 |
| &nbsp;&nbsp;&nbsp;Loss | 9 |  |  |  |  | 9 |  |  | 9 |
| &nbsp;&nbsp;&nbsp;Loans not formally risk rated <sup>(1)</sup> |  | 14814 | 57344 | 36789 | 3615 | 38833 | 56483 | 5045 | 212923 |
| Total |  | $346130 | $753470 | $599235 | $872822 | $1043818 | $1542067 | $1062723 | $6220265 |
| Current period gross charge-offs |  | $— | $— | $164 | $91 | $7568 | $6005 | $7 | $13835 |

---

(1) Consumer loans are not formally risk rated and included $2.8 million of loans on non-accrual as of March 31, 2026.

[**Table of Contents**](#TOC)

The following table presents the amortized cost of loans receivable by internal risk grade by year of origination as of December 31, 2025. Also presented are current period gross charge-offs by loan type and vintage year for the three months ended December 31, 2025:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** |
|  | <br>**Risk Rating** | **2025** | **2024** | **2023** | **2022** | **2021** | **Prior** | **Revolving Loans** | **Total** |
| **One-to-Four-Family Residential** |  |  |  |  |  |  |  |  |  |
| Grade: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 1-5 | $109894 | $99901 | $133211 | $252202 | $230200 | $310541 | $38849 | $1174798 |
| &nbsp;&nbsp;&nbsp;Special Mention | 6 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Substandard | 7 |  |  |  |  | 239 | 1983 | 136 | 2358 |
| &nbsp;&nbsp;&nbsp;Doubtful | 8 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loss | 9 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loans not formally risk rated <sup>(1)</sup> |  |  |  |  |  |  |  |  |  |
| Total |  | $109894 | $99901 | $133211 | $252202 | $230439 | $312524 | $38985 | $1177156 |
| Current period gross charge-offs |  | $— | $— | $— | $— | $— | $— | $— | $— |
| **Home Equity** |  |  |  |  |  |  |  |  |  |
| Grade: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 1-5 | $— | $481 | $245 | $— | $— | $919 | $149598 | $151243 |
| &nbsp;&nbsp;&nbsp;Special Mention | 6 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Substandard | 7 |  | 62 | 125 |  |  |  | 1172 | 1359 |
| &nbsp;&nbsp;&nbsp;Doubtful | 8 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loss | 9 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loans not formally risk rated <sup>(1)</sup> |  |  |  |  |  |  |  |  |  |
| Total |  | $— | $543 | $370 | $— | $— | $919 | $150770 | $152602 |
| Current period gross charge-offs |  | $— | $— | $— | $— | $— | $— | $— | $— |
| **Commercial Real Estate** |  |  |  |  |  |  |  |  |  |
| Grade: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 1-5 | $277427 | $176824 | $268778 | $350792 | $166603 | $443438 | $109330 | $1793192 |
| &nbsp;&nbsp;&nbsp;Special Mention | 6 |  | 12654 | 33785 | 49323 | 4277 | 6918 |  | 106957 |
| &nbsp;&nbsp;&nbsp;Substandard | 7 |  |  |  | 457 |  | 23437 |  | 23894 |
| &nbsp;&nbsp;&nbsp;Doubtful | 8 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loss | 9 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loans not formally risk rated <sup>(1)</sup> |  |  |  |  |  |  |  |  |  |
| Total |  | $277427 | $189478 | $302563 | $400572 | $170880 | $473793 | $109330 | $1924043 |
| Current period gross charge-offs |  | $— | $— | $— | $18 | $— | $— | $— | $18 |
| **Multi-Family** |  |  |  |  |  |  |  |  |  |
| Grade: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 1-5 | $51330 | $17220 | $79309 | $232302 | $29510 | $106112 | $1744 | $517527 |
| &nbsp;&nbsp;&nbsp;Special Mention | 6 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Substandard | 7 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Doubtful | 8 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loss | 9 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loans not formally risk rated <sup>(1)</sup> |  |  |  |  |  |  |  |  |  |
| Total |  | $51330 | $17220 | $79309 | $232302 | $29510 | $106112 | $1744 | $517527 |
| Current period gross charge-offs |  | $— | $— | $— | $— | $— | $— | $— | $— |
| **Construction and Land Development** |  |  |  |  |  |  |  |  |  |
| Grade: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 1-5 | $95751 | $212670 | $256764 | $13536 | $16138 | $3466 | $99857 | $698182 |
| &nbsp;&nbsp;&nbsp;Special Mention | 6 |  |  |  | 32381 |  |  |  | 32381 |
| &nbsp;&nbsp;&nbsp;Substandard | 7 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Doubtful | 8 |  |  |  |  |  | 10 |  | 10 |
| &nbsp;&nbsp;&nbsp;Loss | 9 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loans not formally risk rated <sup>(1)</sup> |  |  |  |  |  |  |  |  |  |
| Total |  | $95751 | $212670 | $256764 | $45917 | $16138 | $3476 | $99857 | $730573 |
| Current period gross charge-offs |  | $— | $— | $— | $— | $— | $— | $— | $— |
| **Commercial and Industrial** |  |  |  |  |  |  |  |  |  |
| Grade: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 1-5 | $72148 | $65844 | $99436 | $91265 | $106858 | $61608 | $387604 | $884763 |
| &nbsp;&nbsp;&nbsp;Special Mention | 6 |  | 1696 | 2262 | 12851 | 10417 | 4306 | 45454 | 76986 |
| &nbsp;&nbsp;&nbsp;Substandard | 7 | 9500 |  | 2437 | 13835 | 4878 | 8776 | 6389 | 45815 |
| &nbsp;&nbsp;&nbsp;Doubtful | 8 |  |  |  | 105 |  |  |  | 105 |
| &nbsp;&nbsp;&nbsp;Loss | 9 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loans not formally risk rated <sup>(1)</sup> |  |  |  |  |  |  |  |  |  |
| Total |  | $81648 | $67540 | $104135 | $118056 | $122153 | $74690 | $439447 | $1007669 |
| Current period gross charge-offs |  | $— | $— | $— | $— | $— | $3762 | $— | $3762 |

---

[**Table of Contents**](#TOC)

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** | **Term Loans Amortized Cost Basis by Origination Year (in thousands)** |
|  | <br>**Risk Rating** | **2025** | **2024** | **2023** | **2022** | **2021** | **Prior** | **Revolving Loans** | **Total** |
| **Consumer** |  |  |  |  |  |  |  |  |  |
| Grade: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 1-5 | $— | $— | $— | $— | $— | $— | $— | $— |
| &nbsp;&nbsp;&nbsp;Special Mention | 6 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Substandard | 7 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Doubtful | 8 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loss | 9 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loans not formally risk rated <sup>(1)</sup> |  | 56733 | 40589 | 3775 | 41676 | 36574 | 20694 | 3456 | 203497 |
| Total |  | $56733 | $40589 | $3775 | $41676 | $36574 | $20694 | $3456 | $203497 |
| Current period gross charge-offs |  | $144 | $— | $43 | $732 | $374 | $24 | $7 | $1324 |
| **Mortgage Warehouse** |  |  |  |  |  |  |  |  |  |
| Grade: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 1-5 | $— | $— | $— | $— | $— | $— | $280949 | $280949 |
| &nbsp;&nbsp;&nbsp;Special Mention | 6 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Substandard | 7 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Doubtful | 8 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loss | 9 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loans not formally risk rated <sup>(1)</sup> |  |  |  |  |  |  |  |  |  |
| Total |  | $— | $— | $— | $— | $— | $— | $280949 | $280949 |
| Current period gross charge-offs |  | $— | $— | $— | $— | $— | $— | $— | $— |
| **Total Loans** |  |  |  |  |  |  |  |  |  |
| Grade: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 1-5 | $606550 | $572940 | $837743 | $940097 | $549309 | $926084 | $1067931 | $5500654 |
| &nbsp;&nbsp;&nbsp;Special Mention | 6 |  | 14350 | 36047 | 94555 | 14694 | 11224 | 45454 | 216324 |
| &nbsp;&nbsp;&nbsp;Substandard | 7 | 9500 | 62 | 2562 | 14292 | 5117 | 34196 | 7697 | 73426 |
| &nbsp;&nbsp;&nbsp;Doubtful | 8 |  |  |  | 105 |  | 10 |  | 115 |
| &nbsp;&nbsp;&nbsp;Loss | 9 |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Loans not formally risk rated <sup>(1)</sup> |  | 56733 | 40589 | 3775 | 41676 | 36574 | 20694 | 3456 | 203497 |
| Total |  | $672783 | $627941 | $880127 | $1090725 | $605694 | $992208 | $1124538 | $5994016 |
| Current period gross charge-offs |  | $144 | $— | $43 | $750 | $374 | $3786 | $7 | $5104 |

---

(1) Consumer loans are not formally risk rated and included $2.2 million of loans on non-accrual as of December 31, 2025.

The following table presents an analysis of the change in the ACL by major loan segment for the periods stated:

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **For the Three Months Ended March 31, 2026** | **For the Three Months Ended March 31, 2026** | **For the Three Months Ended March 31, 2026** | **For the Three Months Ended March 31, 2026** | **For the Three Months Ended March 31, 2026** | **For the Three Months Ended March 31, 2026** | **For the Three Months Ended March 31, 2026** | **For the Three Months Ended March 31, 2026** | **For the Three Months Ended March 31, 2026** | **For the Three Months Ended March 31, 2026** |
|  | **One-to-Four**<br>**Family**<br>**Residential** | <br>**Home Equity** | <br>**Commercial**<br>**Real Estate** | <br>**Multi-Family** | **Construction** <br>**and Land** <br>**Development** | <br>**Commercial and**<br>**Industrial** | <br>**Consumer** | <br>**Mortgage Warehouse** | <br>**Unallocated** | <br>**Total** |
|  | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Balance at December 31, 2025 | $1703 | $152 | $21599 | $1188 | $5050 | $49599 | $7895 | 225 | $— | $87411 |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for (release of) credit losses | 62 | 3 | 386 | 209 | 154 | 4093 | 1478 | (3) |  | 6382 |
| &nbsp;&nbsp;&nbsp;&nbsp;Charge-offs | (56) |  |  |  |  | (12370) | (1409) |  |  | (13835) |
| &nbsp;&nbsp;&nbsp;&nbsp;Recoveries of loans previously charged-off |  |  |  |  |  | 12 | 225 |  |  | 237 |
| Balance at March 31, 2026 | $1709 | $155 | $21985 | $1397 | $5204 | $41334 | $8189 | $222 | $— | $80195 |
|  | **For the Three Months Ended March 31, 2025** | **For the Three Months Ended March 31, 2025** | **For the Three Months Ended March 31, 2025** | **For the Three Months Ended March 31, 2025** | **For the Three Months Ended March 31, 2025** | **For the Three Months Ended March 31, 2025** | **For the Three Months Ended March 31, 2025** | **For the Three Months Ended March 31, 2025** | **For the Three Months Ended March 31, 2025** | **For the Three Months Ended March 31, 2025** |
|  | **One-to-Four** |  |  |  | **Construction**  |  |  |  |  |  |
|  | **Family** |  | **Commercial** |  | **and Land**  | **Commercial and** |  |  |  |  |
|  | **Residential** | **Home Equity** | **Real Estate** | **Multi-Family** | **Development** | **Industrial** | **Consumer** | **Mortgage Warehouse** | **Unallocated** | **Total** |
|  | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Balance at December 31, 2024 | $1195 | $74 | $9481 | $599 | $4137 | $11174 | $12084 | $— | $— | $38744 |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for (release of) credit losses | 98 | 14 | (723) | 16 | 703 | 901 | (62) |  |  | 947 |
| &nbsp;&nbsp;&nbsp;&nbsp;Charge offs |  |  |  |  |  |  | (1558) |  |  | (1558) |
| &nbsp;&nbsp;&nbsp;&nbsp;Recoveries of loans previously charged off |  |  |  |  |  | 12 | 193 |  |  | 205 |
| Balance at March 31, 2025 | $1293 | $88 | $8758 | $615 | $4840 | $12087 | $10657 | $— | $— | $38338 |

---

The charge-offs in the commercial and industrial portfolio during the quarter ended March 31, 2026 were primarily driven by two large charge-offs of PCD loans, in amounts of $10.6 million and $1.8 million. These loans were previously reserved for through purchase accounting adjustments as of the acquisition date and resulted in no additional loss to the Company.

[**Table of Contents**](#TOC)

The following table presents the amortized cost of collateral-dependent loans as of March 31, 2026 and December 31, 2025:

---

| | | |
|:---|:---|:---|
|  | **As of** | **As of** |
|  | **March 31, 2026** | **December 31, 2025** |
|  | **(in thousands)** | **(in thousands)** |
| Real estate loans: |  |  |
| &nbsp;&nbsp;One to four-family residential | $1690 | $2433 |
| &nbsp;&nbsp;Home equity | 1635 | 1338 |
| &nbsp;&nbsp;Commercial real estate | 18606 | 19057 |
| &nbsp;&nbsp;Construction and land development | 10 | 10 |
| Commercial and industrial loans | 48286 | 62986 |
| Total | $70227 | $85824 |

---

The Company closely monitors the performance of borrowers experiencing financial difficulty to understand the effectiveness of its loan modification efforts.

The following table presents the period end amortized cost basis of loans modified to borrowers experiencing financial difficulty during the three months ended March 31, 2026, disaggregated by class of financing receivable, type of modification granted and the financial effect of the modifications.

---

| | | | |
|:---|:---|:---|:---|
|  | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** |
|  | **Amortized**<br>**Cost Basis** | **% of Total Class of**<br>**Financing Receivable** | <br>**Financial Effect** |
|  | **(In thousands)** |  |  |
| **Interest rate reduction** |  |  |  |
| Commercial real estate | $4334 | 0.2% | Terminated swap, changed interest rate index, reduced spread and added rate floors |
| Total | $4334 |  |  |

---

Modifications to borrowers experiencing financial difficulty were performing in accordance with the modified terms, current and not in default as of March 31, 2026 and December 31, 2025. During the three months ended March 31, 2025, the Company did not modify any loans to borrowers experiencing financial difficulty.

#### Note 5 – Goodwill and Other Intangible Assets
The table below sets forth the carrying amount of goodwill and other intangible assets, net of accumulated amortization as of the dates indicated:

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | **December 31, 2025** |
|  | **(in thousands)** | **(in thousands)** |
| Balances not subject to amortization: |  |  |
| &nbsp;&nbsp;Goodwill | $18512 | $18512 |
| Balances subject to amortization: |  |  |
| &nbsp;&nbsp;Core deposit intangibles | 18411 | 19303 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total goodwill and other intangibles (1) | $36923 | $37815 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) The goodwill recorded during December 31, 2025 relates to the acquisition of Provident.

The changes in the carrying value of goodwill for the periods indicated were as follows:

---

| | | |
|:---|:---|:---|
|  | **For the Three Months Ended** | **For the Three Months Ended** |
|  | **March 31, 2026** | **March 31, 2025** |
|  | **(in thousands)** | **(in thousands)** |
| Balance at beginning of period | $18512 | $— |
| Goodwill recorded during the period |  |  |
| Goodwill disposed of during the period |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at end of period | $18512 | $— |

---

[**Table of Contents**](#TOC)

The following table sets forth the carrying amount of the Company's other intangible assets, net of accumulated amortization, as of the dates indicated below:

---

| | | | |
|:---|:---|:---|:---|
|  | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** |
|  | **Gross Carrying Amount** | **Accumulated Amortization** | **Net Carrying Amount** |
|  | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Core deposit intangible - Provident | $18800 | $1283 | $17517 |
| Core deposit intangible - Century Cannabis | 1488 | 594 | 894 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total core deposit intangibles | $20288 | $1877 | $18411 |

---

---

| | | | |
|:---|:---|:---|:---|
|  | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
|  | **Gross Carrying Amount** | **Accumulated Amortization** | **Net Carrying Amount** |
|  | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Core deposit intangible - Provident | 18800 | $428 | $18372 |
| Core deposit intangible - Century Cannabis | 1488 | 557 | 931 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total core deposit intangibles | $20288 | $985 | $19303 |

---

In accordance with the accounting guidance codified in ASC 350-20, the Company performs a test of goodwill for impairment at the reporting segment level on an annual basis, or sooner, if an event occurs or circumstances change which might indicate that the fair value of a reporting unit is below its carrying amount. The Company has one identified reporting segment and assigned goodwill to the banking business reporting segment.

An assessment is also required to be performed to the extent relevant events and/or circumstances occur which may indicate it is more-likely-than-not that the fair value of a reporting segment is less than its carrying amount.

The Company performed its annual assessment for the banking business as of December 31, 2025. The assessment included a qualitative assessment which indicated that it was more likely than not that the fair value of the reporting unit exceeded the carrying value. Based upon the assessment, it was determined there was no impairment of the Company's goodwill as of December 31, 2025.

The amortization expense of the Company's other intangible assets was $892,000 and $37,000 during the three months ended March 31, 2026 and 2025, respectively.

The weighted average original amortization period and weighted average remaining useful life of the Company's other intangible assets is 10.0 years and 9.3 years, respectively. Management performs an assessment of the remaining useful lives of the Company's intangible assets on a quarterly basis to determine if such lives remain appropriate.

The estimated amortization expense for the remaining useful life of the Company's other intangible assets is as follows (in thousands):

---

| | |
|:---|:---|
| **Year** |  |
| 2026 | $2632 |
| 2027 | 3183 |
| 2028 | 2841 |
| 2029 | 2499 |
| 2030 | 2157 |
| 2031 and thereafter | 5099 |
|  | $18411 |

---

#### Note 6 – Employee Benefits
401(k) Plan – The Company has an employee tax deferred incentive plan (the "401(k) plan") under which the Company makes voluntary contributions within certain limitations. All employees who meet specified age and length of service requirements are eligible to participate in the 401(k) plan.

[**Table of Contents**](#TOC)

The amount contributed by the Company to the 401(k) Plan is included in salaries and employee benefits in the consolidated statements of income. The amounts contributed to the 401(k) plan for the three months ended March 31, 2026 and 2025 were $1.1 million and $688,000, respectively.

Employee Pension Plan – The Company provided pension benefits through a defined benefit plan maintained with the Co-operative Banks Employees Retirement Association ("CBERA") (the "Plan"). The Plan was a multi-employer plan whereby the contributions by each bank are not restricted to provide benefits to the employees of the contributing bank; therefore, the Company is not required to recognize the funded status of the plan on its consolidated balance sheet and need only accrue for any quarterly contributions due and payable on demand, or any withdrawal liabilities assessed by CBERA if the Company intended to withdraw from the Plan.

The Company determined to freeze benefit accruals and withdraw from the CBERA Plan as of December 31, 2023. The Company withdrew from the Plan in the second quarter of 2024.

During the three months ended March 31, 2025, as part of the final CBERA Plan liquidation, the Company contributed an additional $1.2 million to the CBERA Plan.

Officers' Deferred Compensation Plan – The Company maintains an unfunded, defined contribution, Non-qualified Deferred Compensation Plan ("Officers' Deferred Comp Plan") for select employees of the Company. The Officers' Deferred Comp Plan was provided to key management of the Company and results in 5% - 20% of the employee's then current base salary being credited to the participant's account annually, subject to increases based upon increases in annual base compensation and the possibility of additional discretionary contributions. The employees vest at varying dates in accordance with each individual's deferred compensation participation agreement; however, all key officers will be fully vested upon the attainment of age 65. The obligations under these plans are included in accrued retirement liabilities in the Company's consolidated balance sheets and approximated $2.5 million and $2.4 million at March 31, 2026 and December 31, 2025, respectively. The expense under the Officers' Deferred Comp Plan (recorded in salaries and employee benefits in the consolidated statements of income) approximated $88,000 and $89,000 for the three months ended March 31, 2026 and 2025, respectively.

Deferred Compensation Plans – The Company maintains an unfunded Non-qualified Deferred Compensation Plan ("Deferred Comp Plan") for select employees of the Company. The Deferred Comp Plan was provided to key management of the Company and allows for the employees to defer amounts from their salary, bonus, or Long-Term Incentive Plan ("LTIP") into the Deferred Comp Plan to be paid out at a future date. Amounts deferred under the Deferred Comp Plan increase in value based upon the growth of the Bank's tangible capital, with the Compensation Committee holding discretionary authority. The obligations under the Deferred Comp Plan are included in accrued retirement liabilities on the Company's consolidated balance sheets and approximated $8.0 million and $5.1 million at March 31, 2026 and December 31, 2025, respectively.

LTIP – In January 2020, the Company put into place a long-term incentive plan for certain members of its management team where benefits are awarded annually on a discretionary basis and cliff vest after three years. Under this plan, individuals are granted "phantom shares" and benefits are accrued based upon the projected growth of the Bank's capital. The obligations under this plan are included in accrued retirement liabilities on the Company's consolidated balance sheets and approximated $3.8 million and $7.2 million as of March 31, 2026 and December 31, 2025, respectively. The expense under this plan (recorded in salaries and employee benefits in the consolidated statements of income) approximated $612,000 and $832,000 for the three months ended March 31, 2026 and 2025, respectively.

Director Pension Plan – The Company has a director defined benefit pension plan ("Director Pension Plan"), covering directors who were in service prior to 2023 and have met the plan's vesting requirements. The Company's liabilities for the Director Pension Plan are calculated by an independent actuary who uses the "projected unit credit" actuarial method to determine the normal cost and actuarial liability. The liability for the Director Pension Plan amounted to $6.9 million and $6.8 million as of March 31, 2026 and December 31, 2025, respectively, and is recorded on the consolidated balance sheets.

[**Table of Contents**](#TOC)

The expense under this plan (recorded in salaries and employee benefits in the consolidated statements of income) approximated $160,000 and $162,000 for the three months ended March 31, 2026 and 2025, respectively.

The Company records an estimate of net periodic pension cost for the director pension plan to accrued retirement liabilities on the consolidated balance sheet on a quarterly basis. Equity adjustments, to accumulated other comprehensive loss, in conjunction with the pension plan are recorded by the Company annually upon receipt of the independent actuarial report.

Employment and Change in Control Agreements – The Company entered into an employment agreement with the Chief Executive Officer that renews for one additional year each January 1<sup>st</sup>. During 2025, the Company entered into Change in Control agreements with certain executive officers, which provide severance payments in the event of the executive's involuntary or constructive termination of employment, including upon a termination following a change in control as defined in the agreements.

Employee Stock Ownership Plan *–* As part of the Initial Public Offering ("IPO") completed on December 27, 2023, the Bank established a tax-qualified Employee Stock Ownership Plan ("ESOP") to provide eligible employees the opportunity to own Company shares. The ESOP borrowed $47.2 million from the Company to purchase 3,416,458 common shares on the open market.

The original loan was payable in annual installments over 20 years at an interest rate of 8.50%. During the year ended December 31, 2025, the loan was refinanced into annual installments over the remaining 19 years at an interest rate of 7.50%. As the loan is repaid to the Company, shares are released and allocated proportionally to eligible participants on the basis of each participant's proportional share of compensation relative to the compensation of all participants. The unallocated ESOP shares are pledged as collateral on the loan. The Company accounts for its ESOP in accordance with *FASB ASC 718-40, Compensation – Stock Compensation*.

Under this guidance, unreleased shares are deducted from shareholders' equity as unearned ESOP shares on the accompanying consolidated balance sheets.

The Company recognizes compensation expense equal to the fair value of the ESOP shares during the periods in which they are committed to be released. To the extent that the fair value of the Company's ESOP shares differs from the cost of such shares, the difference will be credited or debited to shareholders' equity.

As the loan is internally leveraged, the loan receivable from the ESOP to the Company is not reported as an asset nor is the debt of the ESOP shown as a liability on the Company's consolidated balance sheets. Total compensation expense recognized in connection with the ESOP was $885,000 and $783,000 for the three months ended March 31, 2026 and 2025, respectively.

The following table presents share information held by the ESOP:

---

| | | |
|:---|:---|:---|
|  | **As of** | **As of** |
|  | **March 31, 2026** | **December 31, 2025** |
|  | **(Dollars in thousands)** | **(Dollars in thousands)** |
| Allocated shares | 170823 | 170823 |
| Shares committed to be released | 42121 | 170823 |
| Unallocated shares | 3203514 | 3074812 |
| &nbsp;&nbsp;Total shares | 3416458 | 3416458 |
| Fair value of unallocated shares | $67498 | $60943 |

---

Stock-Based Compensation *–* On April 23, 2025, the shareholders of the Company approved the NB Bancorp, Inc. 2025 Equity Incentive Plan ("2025 Plan"). The 2025 Plan provides for the issuance of up to 5,987,802 shares of common stock pursuant to grants of restricted stock awards ("RSAs"), restricted stock units ("RSUs"), non-qualified stock options and incentive stock options, any or all of which can be granted with performance-based vesting conditions.

[**Table of Contents**](#TOC)

Under the 2025 Plan, 1,708,229 shares may be issued as RSAs or RSUs, including those issued as performance shares and PSUs, and 4,270,573 shares may be issued upon the exercise of stock options. These shares may be awarded from the Company's authorized but unissued shares. However, the 2025 Plan permits the grant of additional awards of restricted stock or RSUs above the aforementioned limit, provided that, for each additional share of RSA or RSU awarded in excess of such limit, the pool of shares available to be issued upon the exercise of stock options will be reduced by three shares.

The following table presents RSA activity for the periods indicated (dollars in thousands).

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** |
|  | **Number of Shares** | **Weighted-Average Grant Date Fair Value Per Share** | **Number of Shares** | **Weighted-Average Grant Date Fair Value Per Share** |
| Non-vested balance at beginning of period | 1284525 | $16.41 |  | $— |
| &nbsp;&nbsp;Granted | 283559 | 21.64 |  |  |
| &nbsp;&nbsp;Vested |  |  |  |  |
| &nbsp;&nbsp;Forfeited |  |  |  |  |
| Non-vested balance at end of period | 1568084 | $17.36 |  | $— |

---

The following table presents stock-based compensation expense for the periods indicated.

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** |
|  | **March 31, 2026** | **March 31, 2025** |
|  | **(in thousands)** | **(in thousands)** |
| Stock-based compensation expense: |  |  |
| &nbsp;&nbsp;Restricted stock awards | $1443 | $— |
| Total stock-based compensation expense | $1443 | $— |
| Related tax benefits recognized in earnings | $— | $— |

---

During the three months ended March 31, 2026, the Company granted 283,559 shares of restricted stock with a weighted-average grant date fair value per share of $21.64 and recognized $1.4 million of stock compensation expense. The Company did not have any restricted stock activity or recognize any stock compensation expense during the three months ended March 31, 2025.

Unrecognized stock compensation expense, which is included in Additional Paid-in Capital on the Consolidated Balance Sheets was $22.9 million and $18.2 million at March 31, 2026 and December 31, 2025, respectively.

#### Note 7 – Fair Value Measurements
*ASC 820-10, Fair Value Measurement – Overall ("ASC 820-10")*, provides a framework for measuring fair value under U.S. GAAP. This guidance also allows the Company the irrevocable option to elect fair value for the initial and subsequent measurement for certain financial assets and liabilities on a contract-by-contract basis.

In accordance with *ASC 820-10*, the Company groups its financial assets and financial liabilities measured at fair value in three levels, based on the markets in which the assets and liabilities are traded and the reliability of the assumptions used to determine fair value.

Level 1 – Valuations for assets and liabilities traded in active exchange markets, such as the New York Stock Exchange. Valuations are obtained from readily available pricing sources for market transactions involving identical assets or liabilities.

Level 2 – Valuations for assets and liabilities traded in less active dealer or broker markets. Valuations are obtained from third party pricing services for identical or comparable assets or liabilities.

[**Table of Contents**](#TOC)

Level 3 – Valuations for assets and liabilities that are derived from other methodologies, including option pricing models, discounted cash flow models and similar techniques, and are not based on market exchange, dealer, or broker traded transactions. Level 3 valuations incorporate certain assumptions and projections in determining the fair value assigned to such assets and liabilities.

A financial instrument's level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement.

A description of the valuation methodologies used for instruments measured at fair value, as well as the general classification of such instruments pursuant to the valuation hierarchy, is set forth below. These valuation methodologies were applied to all of the Company's financial assets and financial liabilities carried at fair value for March 31, 2026 and December 31, 2025.

**AFS securities** – Where quoted prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. Level 1 securities would include highly liquid government bonds (such as U.S. Treasuries), mortgage products and exchange traded equities. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics, or discounted cash flows. Level 2 securities would include U.S. agency securities, mortgage-backed agency securities, obligations of states and political subdivisions, and certain corporate, asset-backed and other securities. In certain cases where there is limited activity or less transparency around inputs to the valuation, securities are classified within Level 3 of the valuation hierarchy.

**Derivative arrangements –** The fair values of derivative arrangements are estimated by the Company using a third-party derivative valuation expert who relies on Level 2 inputs, namely discounted cash flow models to determine fair value by calculating a settlement termination value with the counterparty.

Assets measured and reported at estimated fair value on a recurring basis are summarized below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **March 31, 2026** | **Level 1** | **Level 2** | **Level 3** | **Fair Value** |
| Assets: | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| &nbsp;&nbsp;Available-for-sale debt securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Treasury securities | $96321 | $— | $— | $96321 |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Government agencies |  | 4686 |  | 4686 |
| &nbsp;&nbsp;&nbsp;&nbsp;Agency mortgage-backed securities |  | 89853 |  | 89853 |
| &nbsp;&nbsp;&nbsp;&nbsp;Agency collateralized mortgage obligations |  | 11387 |  | 11387 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate bonds |  | 47753 | 14244 | 61997 |
| &nbsp;&nbsp;&nbsp;&nbsp;Municipal obligations |  | 6540 |  | 6540 |
| &nbsp;&nbsp;&nbsp;&nbsp;SBA securities |  | 6457 |  | 6457 |
| Total available-for-sale debt securities | $96321 | $166676 | $14244 | $277241 |
| &nbsp;&nbsp;Derivative assets | $— | $20527 | $— | $20527 |
| Liabilities: |  |  |  |  |
| &nbsp;&nbsp;Derivative liabilities | $— | $21249 | $— | $21249 |

---

[**Table of Contents**](#TOC)

---

| | | | | |
|:---|:---|:---|:---|:---|
| **December 31, 2025** | **Level 1** | **Level 2** | **Level 3** | **Fair Value** |
| Assets: | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| &nbsp;&nbsp;Available-for-sale debt securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Treasury securities | $95783 | $— | $— | $95783 |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Government agencies |  | 9212 |  | 9212 |
| &nbsp;&nbsp;&nbsp;&nbsp;Agency mortgage-backed securities |  | 68591 |  | 68591 |
| &nbsp;&nbsp;&nbsp;&nbsp;Agency collateralized mortgage obligations |  | 12237 |  | 12237 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate bonds |  | 55664 | 14221 | 69885 |
| &nbsp;&nbsp;&nbsp;&nbsp;Municipal obligations |  | 6524 |  | 6524 |
| &nbsp;&nbsp;&nbsp;&nbsp;SBA securities |  | 6727 |  | 6727 |
| Total available-for-sale debt securities | $95783 | $158955 | $14221 | $268959 |
| &nbsp;&nbsp;Derivative assets | $— | $23562 | $— | $23562 |
| Liabilities: |  |  |  |  |
| &nbsp;&nbsp;Derivative liabilities | $— | $22295 | $— | $22295 |

---

The Company had no purchases, sales or transfers of Level 3 assets during the three months ended March 31, 2026 and 2025. The changes in Level 3 assets during the three months ended March 31, 2026 and 2025 are attributable to total net gains (losses) included in Other Comprehensive Income on subordinated debentures.

The Company may also be required from time to time to measure certain other assets on a non-recurring basis in accordance with U.S. GAAP. Any adjustments to fair value usually result in write-downs of individual assets.

**Collateral-Dependent Loans** – Collateral-dependent loans with specific reserves are carried at fair value, which equals the estimated market value of the collateral less estimated costs to sell. A loan may have multiple types of collateral; however, the majority of the Company's loan collateral is real estate. The value of real estate collateral is generally determined utilizing a market valuation approach based on an appraisal conducted by an independent, licensed appraiser outside of the Company using observable market data (Level 2). However, if the collateral value is significantly adjusted due to differences in the comparable properties or is discounted by the Company because of lack of marketability, then the fair value is considered Level 3.

The value of business equipment is based upon an outside appraisal if deemed significant or the net book value on the applicable borrower's financial statements if not considered significant.

Likewise, values for inventory and accounts receivables collateral are based on financial statement balances or aging reports (Level 3). Fair value adjustments are recorded in the period incurred as provision for credit losses on the consolidated statements of income.

Enterprise value is defined as imputed value for the entire underlying business. To determine an appropriate range of enterprise value, management relies on a standardized set of valuation methodologies that take into account future projected cash flows, market-based multiples, as well as asset values. Valuations involve both quantitative and qualitative considerations and professional judgments concerning differences in financial and operating characteristics in addition to other factors that may impact values over time (Level 3).

The Company had no liabilities measured at fair value on a non-recurring basis.

[**Table of Contents**](#TOC)

The following table summarizes assets measured at fair value on a non-recurring basis:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** |
|  | **Level 1** | **Level 2** | **Level 3** | **Fair Value** |
|  | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Collateral-dependent loans, net of reserve | $— | $— | $39632 | $39632 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
|  | **Level 1** | **Level 2** | **Level 3** | **Fair Value** |
|  | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Collateral-dependent loans, net of reserve | $— | $— | $42041 | $42041 |

---

For Level 3 assets and liabilities measured at fair value on a nonrecurring basis as of March 31, 2026 and December 31, 2025, the significant unobservable inputs used in the fair value measurements were as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **Significant**<br>**Valuation**<br>**Technique** | **Significant**<br>**Observable**<br>**Inputs** | &nbsp;&nbsp;&nbsp;&nbsp; <br>**Unobservable**<br>**Inputs** |
| Collateral-dependent loans | Appraisal Value / Comparison Sales / Enterprise Value | Appraisals and/or sales of comparable properties or financial statements of the business | Appraisals discounted 5 to 20% for sales commission and other holding costs; Enterprise value discounts of assets, liabilities and equity; industry Earnings Before Interest, Taxes, Depreciation and Amortization multiples |

---

*ASC Topic 825, Financial Instruments (ASC 825)*, requires disclosure of the fair value of financial assets and financial liabilities, including those financial assets and financial liabilities that are not measured and reported at fair value on a recurring or non-recurring basis. The methodologies for estimating the fair value of financial assets and financial liabilities that are measured at fair value on a recurring or non-recurring basis are discussed above.

*ASC 825* requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes. The exit price notion is a market-based measurement of fair value that is represented by the price to sell an asset or transfer a liability in the principal market (or most advantageous market in the absence of a principal market) on the measurement date. As of March 31, 2026 and December 31, 2025, fair values of loans are estimated on an exit price basis incorporating discounts for credit, liquidity and marketability factors.

The following tables present the estimated fair values, related carrying amounts, and valuation level of the financial instruments as of the dates stated:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** |
|  | **Carrying**<br>**Amount** | **Fair**<br>**Value** | <br>**Level 1** | <br>**Level 2** | <br>**Level 3** |
|  | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** |
| Financial Assets: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $375357 | $375357 | $375357 | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Loans held for sale, at fair value | 63971 | 63971 | 63971 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Loans receivable, net | 6129715 | 6207104 |  |  | 6207104 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued interest receivable | 27150 | 27150 | 27150 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-public investments | 40738 | 40738 |  | 23465 | 17273 |
| &nbsp;&nbsp;&nbsp;&nbsp;BOLI | 110586 | 110586 |  | 110586 |  |
| Financial Liabilities: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Deposits, other than time deposits | $3518621 | $3518621 | $3518621 | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Time deposits | 2578367 | 2578013 |  | 2578013 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;FHLB borrowings | 189701 | 186033 |  | 186033 |  |

---

[**Table of Contents**](#TOC)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
|  | **Carrying**<br>**Amount** | **Fair**<br>**Value** | <br>**Level 1** | <br>**Level 2** | <br>**Level 3** |
|  | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** |
| Financial Assets: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $407596 | $407596 | $407596 | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Loans held for sale, at fair value | 66447 | 66447 | 66447 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Loans receivable, net | 5898729 | 5893652 |  |  | 5893652 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued interest receivable | 25390 | 25390 | 25390 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-public investments | 33740 | 33740 |  | 16594 | 17146 |
| &nbsp;&nbsp;&nbsp;&nbsp;BOLI | 104335 | 104335 |  | 104335 |  |
| Financial Liabilities: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Deposits, other than time deposits | $3348643 | $3348643 | $3348643 | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Time deposits | 2504891 | 2506499 |  | 2506499 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;FHLB borrowings | 196235 | 191970 |  | 191970 |  |

---

#### Note 8 – Commitments and Contingencies
The Company is party to financial instruments with off-balance sheet risk in the normal course of business to meet the financing needs of its customers. These financial instruments include commitments to originate loans, to disburse funds to borrowers on unused construction and land development loans, and to disburse funds on committed but unused lines of credit.

These financial agreements involve, to varying degrees, elements of credit and interest rate risk in excess of the amount recognized in the consolidated balance sheets. The contract amounts of these instruments reflect the extent of involvement the Company has in particular classes of financial instruments.

Commitments to originate loans and disburse additional funds to borrowers on lines of credit are agreements to lend to a customer provided there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require payment of a fee. The Company evaluates each customer's creditworthiness on a case-by-case basis. The amount of collateral obtained, if deemed necessary by the Company upon extension of credit, is based on management's credit evaluation of the borrower.

The Company's exposure to credit loss in the event of nonperformance by the other party to the financial instrument for loan commitments, is represented by the contractual amount of those instruments. The Company uses the same credit policies in making commitments and conditional obligations as it does for on-balance sheet instruments. The commitments to originate loans and lines of credit may expire without being funded or drawn upon; therefore, the total commitment amounts do not necessarily represent future cash requirements.

Standby letters of credit are conditional commitments issued by the Company to guarantee the performance by a customer to a third party. The credit risk involved in issuing letters of credit is essentially the same as that involved in extending loan facilities to customers. As of March 31, 2026 and December 31, 2025, the maximum potential amount of the Company's obligation was $9.0 million for standby letters of credit. The Company's outstanding letters of credit generally have a term of less than one year. If a letter of credit is drawn upon, the Company may seek recourse through the customer's underlying line of credit. If the customer's line of credit is also in default, the Company may take possession of the collateral, if any, securing the line of credit.

[**Table of Contents**](#TOC)

Financial instruments whose contract amounts represents off-balance sheet credit risk and are not reflected on the Company's consolidated balance sheets consist of the following at the dates stated:

---

| | | |
|:---|:---|:---|
|  | **As of** | **As of** |
|  | **March 31, 2026** | **December 31, 2025** |
|  | **(In thousands)** | **(In thousands)** |
| Commitments to originate loans | $11298 | $45391 |
| Unadvanced funds on lines of credit | 822843 | 742375 |
| Unadvanced funds on construction loans | 380397 | 409180 |
| Unadvanced funds on mortgage warehouse loans | 386744 |  |
| Letters of credit | 8977 | 9013 |
|  | $1610259 | $1205959 |

---

The Bank accrues for credit losses related to off-balance sheet financial instruments. Potential losses on off-balance sheet loan commitments are estimated using the same risk factors used to determine the allowance for credit losses on loans, adjusted for the likelihood that funding will occur. The allowance for off-balance sheet commitments is recorded within other liabilities on the consolidated balance sheets and amounted to $3.3 million as of March 31, 2026 and December 31, 2025. For the three months ended March 31, 2026 and 2025, the Company recorded a release of credit losses on unfunded commitments of $54,000 and a provision for credit losses on unfunded commitments of $211,000, respectively.

#### Note 9 – Derivatives and Hedging Activities
Risk Management Objective of Using Derivatives – The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities.

The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates.

The Company's derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company's known or expected cash receipts and its known or expected cash payments principally related to the Company's assets and liabilities.

Interest Rate Positions – The Company may utilize various interest rate derivatives as hedging instruments against interest rate risk associated with the Company's borrowings and loan portfolios. An interest rate derivative is an agreement whereby one party agrees to pay a floating rate of interest on a notional principal amount in exchange for receiving a fixed rate of interest on the same notional amount, for a predetermined period of time, from a second party. The amounts relating to the notional principal amount are not actually exchanged.

The following tables reflect information about the Company's derivative positions at the dates indicated below for interest rate swaps which qualify as cash flow hedges for accounting purposes, included in prepaid expenses and other assets on the consolidated balance sheet.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** |
|  | | | **Weighted Average Rate** | **Weighted Average Rate** | |
|  | <br>**Notional**<br>**Amount** | <br>**Weighted Average**<br>**Maturity** | **Current Rate**<br>**Paid** | **Current Rate**<br>**Received** | <br>**Fair Value**<br>**Asset (Liability)** |
|  | **(in thousands)** | **(in years)** |  |  | **(in thousands)** |
| Interest rate swaps | $300000 | 2.8 | 3.64% | 3.44% | $(711) |
| Total | $300000 |  |  |  | $(711) |

---

[**Table of Contents**](#TOC)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
|  | | | **Weighted Average Rate** | **Weighted Average Rate** | |
|  | <br>**Notional**<br>**Amount** | <br>**Weighted Average**<br>**Maturity** | **Current Rate**<br>**Paid** | **Current Rate**<br>**Received** | <br>**Fair Value**<br>**Asset (Liability)** |
|  | **(in thousands)** | **(in years)** |  |  | **(in thousands)** |
| Interest rate swaps | $300000 | 3.5 | 3.87% | 3.44% | $1284 |
| Total | $300000 |  |  |  | $1284 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Asset balances are recorded in prepaid expenses and other assets on the consolidated balance sheets. Liability balances are recorded in accrued expenses and other liabilities on the consolidated balance sheets.

The maximum length of time over which the Company is currently hedging its exposure to the variability in future cash flows for forecasted transactions related to the payment of variable interest on existing financial instruments is 3 years. Included in the table above is a forward-starting interest rate swap with a notional amount of $150 million, which does not begin exchanging cash flows until the third quarter of 2026 and carries a 3-year term during the swap period.

For derivative instruments that are designated and qualify as cash flow hedging instruments, the effective portion of the gains or losses is reported as a component of OCI and is subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. The Company expects approximately $492,000 (pre-tax) to be reclassified as an increase to net interest income from OCI related to the Company's cash flow hedges in the twelve months following March 31, 2026.

This reclassification is due to anticipated payments that will be made and/or received on the swaps based on the forward curve at March 31, 2026. The company had no hedges in place for the quarter ended March 31, 2025.

Non-designated Hedges – Derivatives not designated as hedges are not speculative and are used to manage the Company's exposure to interest rate movements and other identified risks but do not meet the strict hedge accounting requirements and/or the Company has not elected apply hedge accounting. Changes air value of derivatives not designated in hedging relationships, exclusive of credit valuation adjustments, are recorded directly in earnings. The Company executes interest rate swaps and cap agreements with commercial banking customers to facilitate its respective risk management strategies. Those interest rate swap and cap agreements are simultaneously hedged by offsetting interest rate swaps and caps that are executed with a third party, such that the Company minimizes its net risk exposure resulting from such transactions.

Risk Participation Agreements ("RPAs") – RPAs are guarantees issued by the Company to other parties for a fee, whereby the Company agrees to participate in the credit risk of a derivative customer of the other party. Under the terms of these agreements, the "participating bank" receives a fee from the "lead bank" in exchange for the guarantee of reimbursement if the customer defaults on an interest rate swap.

The interest rate swap is transacted such that any and all exchanges of interest payments (favorable and unfavorable) are made between the lead bank and the customer. In the event that an early termination of the swap occurs, and the customer is unable to make a required close out payment, the participating bank assumes that obligation and is required to make this payment. RPAs where the Company acts as the lead bank are referred to as "participations-out," in reference to the credit risk associated with the customer derivatives being transferred out of the Company. Participations-out generally occur concurrently with the sale of new customer derivatives. RPAs where the Company acts as the participating bank are referred to as "participations-in," in reference to the credit risk associated with the counterparty's derivatives being assumed by the Company. The Company's maximum credit exposure is based on its proportionate share of the settlement amount of the referenced interest rate swap. Settlement amounts are generally calculated based on the fair value of the swap plus outstanding accrued interest receivable from the customer.

[**Table of Contents**](#TOC)

The table below presents the number of positions and total notional amount of non-designated hedges and RPAs as of the dates stated:

---

| | | |
|:---|:---|:---|
| <br>**March 31, 2026** | <br>**Number of Positions** | **Total**<br>**Notional** |
| Derivatives not designated as hedging instruments: |  | **(in thousands)** |
| &nbsp;&nbsp;Interest rate products | 78 | $554191 |
| &nbsp;&nbsp;RPA credit contracts | 17 | 44565 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total derivatives not designated as hedging instruments |  | $598756 |
|  |  | **Total** |
| **December 31, 2025** | **Number of Positions** | **Notional** |
| Derivatives not designated as hedging instruments: |  | **(in thousands)** |
| &nbsp;&nbsp;Interest rate products | 75 | $532972 |
| &nbsp;&nbsp;RPA credit contracts | 17 | 44634 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total derivatives not designated as hedging instruments |  | $577606 |

---

Tabular Disclosure of Fair Values of Derivative Instruments on the Consolidated Balance Sheet – The table below presents the fair value of the Company's derivative financial instruments not designated as hedging instruments, as well as their classification on the consolidated balance sheets as of the dates stated:

---

| | | |
|:---|:---|:---|
| | **Derivative**<br>**Assets (1)** | **Derivative**<br>**Liabilities (2)** |
| <br>**March 31, 2026** | **(in thousands)** | **(in thousands)** |
| Derivatives not designated as hedging instruments: |  |  |
| &nbsp;&nbsp;Interest rate products | $20538 | $20538 |
| &nbsp;&nbsp;RPA credit contracts |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total derivatives not designated as hedging instruments | $20538 | $20538 |
| **December 31, 2025** |  |  |
| Derivatives not designated as hedging instruments: |  |  |
| &nbsp;&nbsp;Interest rate products | $22294 | $22294 |
| &nbsp;&nbsp;RPA credit contracts |  | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total derivatives not designated as hedging instruments | $22294 | $22295 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Recorded in prepaid expenses and other assets on the consolidated balance sheets.

&nbsp;&nbsp;&nbsp;&nbsp;(2) Recorded in accrued expenses and other liabilities on the consolidated balance sheets.

Swap contract fees, net of brokerage costs, recognized in earnings on the above noted interest rate products and RPA contracts approximated $200,000 and $89,000 for the three months ended March 31, 2026 and 2025, respectively.

The Company has agreements with each of its derivative counterparties that contain a provision where if the Company defaults (or is capable of being declared in default) on any of its indebtedness, then the Company could also be declared in default on its derivative obligations, and it could be required to terminate its derivative positions with the counterparty.

The Company also has agreements with certain of its derivative counterparties that contain a provision whereby if the counterparty fails to maintain its status as a well-capitalized institution, then the Company could be required to terminate its derivative positions with the counterparty.

In order to mitigate counterparty default risk in conjunction with these interest rate products and RPA credit contracts, the Company was required to maintain $9.1 million of collateral deposit accounts with the counterparties to these agreements as of March 31, 2026 and December 31, 2025.

[**Table of Contents**](#TOC)

#### Note 10 – Other Comprehensive Income
U.S. GAAP generally requires that recognized revenue, expenses, gains and losses be included in net income. Although certain changes in assets and liabilities are reported as a separate component of the shareholders' equity section of the consolidated balance sheets, such items, along with net income, are components of comprehensive income (loss).

The components of other comprehensive income (loss) and related tax effects are as follows for the periods indicated:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **For the Three Months Ended**  | **For the Three Months Ended**  | **For the Three Months Ended**  | **For the Three Months Ended**  | **For the Three Months Ended**  | **For the Three Months Ended**  |
|  | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2025** | **March 31, 2025** | **March 31, 2025** |
|  | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** |
|  |  | **Tax** |  |  | **Tax** |  |
|  | **Pre-Tax** | **(Expense)** | **After-Tax** | **Pre-Tax** | **(Expense)** | **After-Tax** |
|  | **Amount** | **Benefit** | **Amount** | **Amount** | **Benefit** | **Amount** |
| Change in fair value of available-for-sale securities | $(1331) | $330 | $(1001) | $2291 | $(589) | $1702 |
| &nbsp;&nbsp;Less: Reclassification adjustment for realized gains (losses) in net income |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in fair value of available-for-sale securities | (1331) | 330 | (1001) | 2291 | (589) | 1702 |
| Change in fair value of cash flow hedges | (1995) | 499 | (1496) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of cash flow hedge, net of tax | (1995) | 499 | (1496) |  |  |  |
| Total other comprehensive income (loss) | $(3326) | $829 | $(2497) | $2291 | $(589) | $1702 |

---

The following table presents the components of accumulated other comprehensive loss as of March 31, 2026 and December 31, 2025:

---

| | | |
|:---|:---|:---|
|  | **As of** | **As of** |
|  | **March 31, 2026** | **December 31, 2025** |
|  | **(In thousands)** | **(In thousands)** |
| Net unrealized holding losses on available-for-sale securities, net of tax | $(3638) | $(2637) |
| Net unrealized (loss) gain on cash flow hedge, net of tax | (533) | 964 |
| Unrecognized director pension plan benefits, net of tax | (1462) | (1463) |
| &nbsp;&nbsp;Total accumulated other comprehensive loss | $(5633) | $(3136) |

---

#### Note 11 – Regulatory Capital Requirements
The Company is subject to various regulatory capital requirements administered by the federal banking agencies. Failure to meet minimum capital requirements can initiate certain mandatory and possibly additional discretionary actions by regulators that, if undertaken, could have a direct material effect on the Company's consolidated financial statements.

Under regulatory capital adequacy guidelines and the regulatory framework for prompt corrective action, the Company must meet specific capital guidelines that involve quantitative measures of the Company's assets, liabilities, and certain off-balance-sheet items as calculated under regulatory accounting practices. The Company's capital amounts and classification are also subject to qualitative judgments by the regulators about components, risk weightings, and other factors.

The Company operated under the risk-based framework as of March 31, 2026 and December 31, 2025.

Under this framework, quantitative measures established by regulation to ensure capital adequacy require the Company to maintain minimum amounts and ratios of Total Capital, Tier 1 Capital and Common Equity Tier 1 Capital to Risk-Weighted Assets, and Tier 1 Capital to Total Average Assets (as defined in the regulations). Management believes, as of March 31, 2026 and December 31, 2025, that the Company and the Bank meet all capital adequacy requirements to which each is subject.

[**Table of Contents**](#TOC)

As of March 31, 2026 and December 31, 2025, the Company and the Bank were categorized as well capitalized under the regulatory framework for prompt corrective action.

To be categorized as well capitalized, the Bank must maintain minimum total risk-based, Tier 1 risk-based, Common Equity Tier 1 risk-based and Tier 1 leverage ratios as set forth in the table below. There are no conditions or events since that notification that management believes have changed the Bank's category. The Bank's actual capital amounts and ratios are presented in the table as of the date indicated:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| |  |  |  |  | **To be well capitalized** | **To be well capitalized** |
| |  |  | **For minimum capital**  | **For minimum capital**  | **under prompt corrective** | **under prompt corrective** |
| | **Actual** | **Actual** | **adequacy purposes** | **adequacy purposes** | **action provisions** | **action provisions** |
| | **Amount** | **Ratio** | **Amount** | **Ratio** | **Amount** | **Ratio** |
| <br>**March 31, 2026** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Total Capital | $812238 | 12.2% | $531937 | 8.0% | $664922 | 10.0% |
| (to Risk-Weighted Assets) |  |  |  |  |  |  |
| Tier 1 Capital | 757905 | 11.4% | 398953 | 6.0% | 531937 | 8.0% |
| (to Risk-Weighted Assets) |  |  |  |  |  |  |
| Common Equity Tier I Capital | 757905 | 11.4% | 299215 | 4.5% | 432199 | 6.5% |
| (to Risk-Weighted Assets) |  |  |  |  |  |  |
| Tier 1 Capital | 757905 | 11.0% | 274662 | 4.0% | 343328 | 5.0% |
| (to Total Average Assets) |  |  |  |  |  |  |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| |  |  |  |  | **To be well capitalized** | **To be well capitalized** |
| |  |  | **For minimum capital**  | **For minimum capital**  | **under prompt corrective** | **under prompt corrective** |
| | **Actual** | **Actual** | **adequacy purposes** | **adequacy purposes** | **action provisions** | **action provisions** |
| | **Amount** | **Ratio** | **Amount** | **Ratio** | **Amount** | **Ratio** |
| <br>**December 31, 2025** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Total Capital | $791298 | 12.4% | $511589 | 8.0% | $639486 | 10.0% |
| (to Risk-Weighted Assets) |  |  |  |  |  |  |
| Tier 1 Capital | 742881 | 11.6% | 383692 | 6.0% | 511589 | 8.0% |
| (to Risk-Weighted Assets) |  |  |  |  |  |  |
| Common Equity Tier I Capital | 742881 | 11.6% | 287769 | 4.5% | 415666 | 6.5% |
| (to Risk-Weighted Assets) |  |  |  |  |  |  |
| Tier 1 Capital | 742881 | 12.2% | 244395 | 4.0% | 305494 | 5.0% |
| (to Total Average Assets) |  |  |  |  |  |  |

---

#### The Company's actual consolidated capital amounts and ratios are presented in the table as of the date indicated:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| |  |  |  |  | **To be well capitalized** | **To be well capitalized** |
| |  |  | **For minimum capital**  | **For minimum capital**  | **under prompt corrective** | **under prompt corrective** |
| | **Actual** | **Actual** | **adequacy purposes** | **adequacy purposes** | **action provisions** | **action provisions** |
| | **Amount** | **Ratio** | **Amount** | **Ratio** | **Amount** | **Ratio** |
| <br>**March 31, 2026** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Total Capital | $863940 | 13.0% | $531338 | 8.0% | $664173 | 10.0% |
| (to Risk-Weighted Assets) |  |  |  |  |  |  |
| Tier 1 Capital | 809607 | 12.2% | 398504 | 6.0% | 531338 | 8.0% |
| (to Risk-Weighted Assets) |  |  |  |  |  |  |
| Common Equity Tier I Capital | 809607 | 12.2% | 298878 | 4.5% | 431713 | 6.5% |
| (to Risk-Weighted Assets) |  |  |  |  |  |  |
| Tier 1 Capital | 809607 | 11.7% | 277376 | 4.0% | 346720 | 5.0% |
| (to Total Average Assets) |  |  |  |  |  |  |

---

[**Table of Contents**](#TOC)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| |  |  |  |  | **To be well capitalized** | **To be well capitalized** |
| |  |  | **For minimum capital**  | **For minimum capital**  | **under prompt corrective** | **under prompt corrective** |
| | **Actual** | **Actual** | **adequacy purposes** | **adequacy purposes** | **action provisions** | **action provisions** |
| | **Amount** | **Ratio** | **Amount** | **Ratio** | **Amount** | **Ratio** |
| <br>**December 31, 2025** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Total Capital | $871043 | 13.6% | $512904 | 8.0% | $641130 | 10.0% |
| (to Risk-Weighted Assets) |  |  |  |  |  |  |
| Tier 1 Capital | 822626 | 12.8% | 384678 | 6.0% | 512904 | 8.0% |
| (to Risk-Weighted Assets) |  |  |  |  |  |  |
| Common Equity Tier I Capital | 822626 | 12.8% | 288508 | 4.5% | 416734 | 6.5% |
| (to Risk-Weighted Assets) |  |  |  |  |  |  |
| Tier 1 Capital | 822626 | 13.3% | 247709 | 4.0% | 309636 | 5.0% |
| (to Total Average Assets) |  |  |  |  |  |  |

---

#### Note 12 – Earnings Per Share ("EPS")
Basic EPS represents net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period.

Diluted EPS have been calculated in a manner similar to that of basic EPS except that the weighted average number of common shares outstanding is increased to include the number of additional common shares that would have been outstanding if all potentially dilutive common shares (such as those resulting from the exercise of stock options) were issued during the period, computed using the treasury stock method.

The Company has restricted stock awards that had a dilutive effect during the three months ended March 31, 2026. There were no securities that had a dilutive effect during the three months ended March 31, 2025, and therefore the weighted-average common shares outstanding used to calculate both basic and diluted EPS are the same during the three months ended March 31, 2025. Unallocated ESOP shares are not deemed outstanding for earnings per share calculations.

For the three months ended March 31, 2026 and 2025, there were no anti-dilutive shares.

The table below sets forth our earnings per share for the periods indicated:

---

| | | |
|:---|:---|:---|
|  | **For the Three Months Ended**  | **For the Three Months Ended**  |
|  | **March 31, 2026** | **March 31, 2025** |
|  | **(Dollars in thousands, except per share data)** | **(Dollars in thousands, except per share data)** |
| Net income applicable to common shares | $14984 | $12655 |
| Average number of common shares outstanding | 45463892 | 42001381 |
| &nbsp;&nbsp;Less: average unallocated ESOP shares | (3074812) | (3245635) |
| &nbsp;&nbsp;Less: average unvested restricted stock awards | (1419332) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Average number of common shares outstanding used to calculate basic EPS | 40969748 | 38755746 |
| &nbsp;&nbsp;Add: assumed conversion - unvested restricted stock awards | 451254 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Average number of common shares outstanding used to calculate diluted EPS | 41421002 | 38755746 |
| Earnings per common share - basic | $0.37 | $0.33 |
| Earnings per common share - diluted | $0.36 | $0.33 |

---

[**Table of Contents**](#TOC)

---

| | |
|:---|:---|
| **Item 2.** | **Management's Discussion and Analysis of Financial Condition and Results of Operations** |

---

#### General
Management's discussion and analysis of the financial condition and results of operations at and for the three months ended March 31, 2026 and 2025 is intended to assist in understanding the financial condition and results of operations of the Company. The information contained in this section should be read in conjunction with the unaudited financial statements and the notes thereto, appearing on Part I, Item 1 of this quarterly report on Form 10-Q.

#### CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains forward-looking statements, which can be identified by the use of words such as "estimate," "project," "believe," "intend," "anticipate," "assume," "plan," "seek," "expect," "will," "may," "should," "could," "might," "indicate," "would," "contemplate," "continue," "target," "forecast," "outlook," "guidance," "objective," "goal," "strategy," "potential," "predict," "projection," "trend," "designed to," "opportunity," "positioned to," and other similar expressions or the negative of these terms. These forward-looking statements include, but are not limited to:

● statements of our goals, intentions and expectations;

● statements regarding our business plans, prospects, growth and operating strategies;

● statements regarding the quality of our loan portfolio; and

● estimates of our risks and future costs and benefits.

These forward-looking statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, these forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change.

The following factors, among others, could cause actual results to differ materially from the anticipated results or other expectations expressed in the forward-looking statements:

● weakening in the United States economy in general and the regional and local economies within the Company's market area;

● the effects of inflationary pressures, labor market shortages and/or supply chain issues;

● the instability or volatility in financial markets and unfavorable general business conditions, globally, nationally or regionally, whether caused by geopolitical concerns, recent disruptions in the banking industry, or other factors;

● unanticipated loan delinquencies, loss of collateral, decreased service revenues, and other potential negative effects on our business caused by severe weather, pandemics or other external events;

● changes in the interest rate environment that reduce our margins and yields, our mortgage banking revenues, the fair value of financial instruments, including our mortgage servicing rights asset, or our level of loan originations, or increase the level of defaults, losses and prepayments on loans we have made and make;

● changes in the level and direction of loan delinquencies and write-offs and changes in estimates of the adequacy of the allowance for credit losses on loans;

[**Table of Contents**](#TOC)

● the effect of any change in federal government enforcement of federal laws affecting the cannabis industry;

● changes in liquidity, including the size and composition of our deposit portfolio, including the percentage of uninsured deposits in the portfolio;

● our ability to access cost-effective funding;

● fluctuations in real estate values and both residential and commercial real estate market conditions;

● demand for loans and deposits in our market area;

● our ability to implement and change our business strategies;

● competition among depository and other financial institutions;

● adverse changes in the securities or secondary mortgage markets;

● changes in laws or government regulations or policies affecting financial institutions, including changes in regulatory fees, capital requirements and insurance premiums;

● changes in the quality or composition of our loan or investment portfolios;

● technological changes that may be more difficult or expensive than expected;

● the inability of third-party providers to perform as expected;

● a failure or breach of our operational or security systems or infrastructure, including cyberattacks;

● our ability to manage market risk, interest rate risk, credit risk, compliance risk, and operational risk;

● our ability to enter new markets successfully and capitalize on growth opportunities;

● changes in consumer spending, borrowing and savings habits;

● changes in accounting policies and practices, as may be adopted by the bank regulatory agencies, the Financial Accounting Standards Board, the Securities and Exchange Commission or the Public Company Accounting Oversight Board;

● our ability to attract and retain key employees; and

● changes in the financial condition, results of operations or future prospects of issuers of securities that we own.

Because of these and a wide variety of other uncertainties, our actual future results may be materially different from the results indicated by these forward-looking statements.

#### Critical Accounting Policies and Estimates
There are no material changes to the critical accounting policies disclosed in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 3, 2026.

[**Table of Contents**](#TOC)

**Non-GAAP Financial Measures** 

In addition to results presented in accordance with U.S. GAAP, this quarterly report on Form 10-Q contains certain non-GAAP financial measures, including pre-provision net revenue, operating net income, operating pre-tax income, operating noninterest expense, operating noninterest income, operating effective tax rate, operating earnings per share, basic, operating earnings per share, diluted, operating return on average assets, operating return on average shareholders' equity, operating efficiency ratio, tangible shareholders' equity, tangible assets and tangible book value per share. The Company presents certain non-GAAP financial measures, which management uses to evaluate the Company's performance, and which exclude the effects of certain transactions, non-cash items and U.S. GAAP adjustments that we believe are unrelated to our core business and are therefore not necessarily indicative of the Company's current performance or financial position. Management believes excluding these items facilitates greater visibility for investors into our core businesses as well as underlying trends that may, to some extent, be obscured by inclusion of such items in the corresponding U.S. GAAP financial measures. These unaudited disclosures should not be viewed as a substitute for financial results determined in accordance with U.S. GAAP, nor are they necessarily comparable to non-GAAP performance measures that may be presented by other companies. Because non-GAAP financial measures are not standardized, it may not be possible to compare these financial measures with other companies' non-GAAP financial measures having the same or similar names.

---

| | | |
|:---|:---|:---|
|  | **For the Three Months Ended**  | **For the Three Months Ended**  |
|  | **March 31, 2026** | **March 31, 2025** |
| Net income (GAAP) | $14984 | $12655 |
| **Add (Subtract):** |  |  |
| Adjustments to net income: |  |  |
| &nbsp;&nbsp;&nbsp;Defined benefit pension termination expense |  | 1217 |
| &nbsp;&nbsp;&nbsp;Non-recurring fees for business line expansion | 500 |  |
| &nbsp;&nbsp;&nbsp;BOLI surrender tax and modified endowment contract penalty | 50 | 154 |
| &nbsp;&nbsp;&nbsp;Merger and acquisition expenses | 534 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total adjustments to net income | $1084 | $1371 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less net tax benefit associated with pre-tax non-GAAP adjustments to net income | (277) | (333) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP adjustments, net of tax | 807 | 1038 |
| **Operating net income (non-GAAP)** | $15791 | $13693 |
| Weighted average common shares outstanding, basic | 40969748 | 38755746 |
| Weighted average common shares outstanding, diluted | 41421002 | 38755746 |
| **Operating earnings per share, basic (non-GAAP)** | $0.39 | $0.35 |
| **Operating earnings per share, diluted (non-GAAP)** | $0.38 | $0.35 |
| Pre-tax income (GAAP) | $20352 | $17569 |
| **Add (Subtract):** |  |  |
| Adjustments to pre-tax income: |  |  |
| &nbsp;&nbsp;&nbsp;Defined benefit pension termination refund |  | 1217 |
| &nbsp;&nbsp;&nbsp;Non-recurring fees for business line expansion | 500 |  |
| &nbsp;&nbsp;&nbsp;Merger and acquisition expenses | 534 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total adjustments to pre-tax income | 1034 | 1217 |
| **Operating pre-tax income (non-GAAP)** | $21386 | $18786 |
| Noninterest expense (GAAP) | $42701 | $28681 |
| **Subtract (Add):** |  |  |
| Adjustments to noninterest expense: |  |  |
| &nbsp;&nbsp;&nbsp;Defined benefit pension termination refund |  | 1217 |
| &nbsp;&nbsp;&nbsp;Non-recurring fees for business line expansion | 500 |  |
| &nbsp;&nbsp;&nbsp;Merger and acquisition expenses | 534 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total impact of non-GAAP noninterest expense adjustments | $1034 | $1217 |
| **Noninterest expense on an operating basis (non-GAAP)** | $41667 | $27464 |
| Operating net income (non-GAAP) | $15791 | $13693 |
| Average assets | 6970059 | 5146528 |
| **Operating return on average assets (non-GAAP)** | 0.92% | 1.08% |
| Average shareholders' equity | $861505 | $757341 |
| **Operating return on average shareholders' equity (non-GAAP)** | 7.43% | 7.33% |
| Noninterest expense on an operating basis (non-GAAP) | $41667 | $27464 |
| Total pre-provision net revenue (net interest income plus total noninterest income) | 69381 | 47408 |
| **Operating efficiency ratio (non-GAAP)** | 60.06% | 57.93% |
| Income tax expense (GAAP) | $5368 | $4914 |
| **Subtract (Add):** |  |  |
| Adjustments to income tax expense: |  |  |
| &nbsp;&nbsp;&nbsp;Net tax benefit associated with pre-tax non-GAAP adjustments to net income | (277) | (333) |
| &nbsp;&nbsp;&nbsp;BOLI surrender tax and modified endowment contract penalty | (50) | (154) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total impact of non-GAAP income tax expense adjustments | $(327) | $(487) |
| **Income tax expense on an operating basis (non-GAAP)** | $5041 | $4427 |
| **Operating effective tax rate (non-GAAP)** | 23.6% | 23.6% |

---

[**Table of Contents**](#TOC)

---

| | | |
|:---|:---|:---|
|  | **As of** | **As of** |
|  | **March 31, 2026** | **December 31, 2025** |
| Total shareholders' equity (GAAP) | $842778 | $858932 |
| **Subtract:** |  |  |
| Intangible assets (core deposit intangible) | 36923 | 37815 |
| **Total tangible shareholders' equity (non-GAAP)** | 805855 | 821117 |
| Total assets (GAAP) | $7226437 | $7006130 |
| **Subtract:** |  |  |
| Intangible assets (core deposit intangible) | 36923 | 37815 |
| **Total tangible assets (non-GAAP)** | $7189514 | $6968315 |
| Tangible shareholders' equity / tangible assets (non-GAAP) | 11.21% | 11.78% |
| Total common shares outstanding | 44765178 | 45770128 |
| **Tangible book value per share (non-GAAP)** | $18.00 | $17.94 |

---

#### Comparison of Financial Condition as of March 31, 2026 and December 31, 2025
***Total Assets.*** Total assets increased $220.3 million, or 3.1%, to $7.23 billion as of March 31, 2026 from $7.01 billion as of December 31, 2025. The increase was primarily driven by increases in net loans, partially offset by decreases in cash and cash equivalents.

***Cash and Cash Equivalents.*** Cash and cash equivalents decreased $32.2 million, or 7.9%, to $375.4 million as of March 31, 2026 from $407.6 million as of December 31, 2025. The decrease in cash and cash equivalents was primarily due to loan originations and the repurchase of 1,288,509 shares totaling $27.8 million, partially offset by the increase in deposits of $243.5 million during the current quarter.

***Available-for-Sale Securities.*** Available-for-sale securities increased $8.3 million, or 3.1%, to $277.2 million as of March 31, 2026 from $269.0 million as of December 31, 2025 primarily due to purchases of U.S. treasuries, mortgage backed-securities and corporate bonds.

***Loans.*** Net loans increased $231.0 million, or 3.9%, to $6.13 billion as of March 31, 2026 from $5.90 billion as of December 31, 2025. The increase resulted primarily from increases in: commercial and industrial loans, which increased $135.4 million, or 13.4%, construction and development loans, which increased $52.1 million, or 7.1% and multi-family residential loans, which increased $20.6 million, or 4.0%. The increase in our loan portfolio reflects our strategy to prudently grow the balance sheet by continuing to diversify into these higher-yielding loans to improve net margins and manage interest rate risk.

The Company had approximately $466.8 million and $404.8 million in loans to borrowers in the cannabis industry at March 31, 2026 and December 31, 2025, respectively. Of that total, $321.0 million and $228.8 million were direct loans to cannabis companies and were primarily collateralized by real estate at March 31, 2026 and December 31, 2025, respectively.

***Deposits.*** Deposits increased $243.5 million, or 4.2%, to $6.10 billion as of March 31, 2026 from $5.85 billion as of December 31, 2025. Core deposits (which we define as all deposits including certificates of deposit, other than brokered deposits) increased $209.1 million, or 3.9%, to $5.53 billion as of March 31, 2026 from $5.32 billion as of December 31, 2025. The increase in deposits was the result of growth in customer deposits, primarily money market accounts, which increased $92.3 million, or 5.6%, noninterest bearings demand deposits of $44.6 million, or 5.4%, certificates of deposit of $39.1 million, or 2.0%, brokered deposits of $34.4 million, or 6.4% and NOW accounts of $30.4 million, or 4.6%.

The Company had $455.6 million and $453.0 million in deposits from the cannabis industry, representing 7.5% and 7.7% of total deposits, as of March 31, 2026 and December 31, 2025, respectively.

***Shareholders' Equity.*** Total shareholders' equity decreased $16.2 million, or 1.9%, to $842.8 million as of March 31, 2026 from $858.9 million as of December 31, 2025, primarily as a result of the repurchase of 1,288,509 shares of common stock at an all-in weighted average cost of $21.55 per share totaling $27.8 million and $3.2 million in dividends paid during the quarter, partially offset by net income of $15.0 million during the three months ended March 31, 2026.

[**Table of Contents**](#TOC)

#### Comparison of Operating Results for the Three Months Ended March 31, 2026 and March 31, 2025
***Net Income.*** Net income was $15.0 million for the quarter ended March 31, 2026, compared to net income of $12.7 million for the quarter ended March 31, 2025, an increase of approximately $2.3 million, or 18.4%. An increase of $21.3 million, or 49.0%, in net interest income was partially offset by a $14.0 million, or 48.9%, increase in noninterest expense and a $5.2 million, or 446.5%, increase in the provision for credit losses.

Operating net income, excluding one-time charges, amounted to $15.8 million, or $0.38 per diluted share, for the quarter ended March 31, 2026, compared to operating net income of $13.7 million, or $0.35 per diluted share, for the quarter ended March 31, 2025, representing an increase of $2.1 million, or 15.3%.

The material one-time charges for the quarter ended March 31, 2026 include:

● Pre-tax trailing merger and acquisition costs of $534 thousand ($390 thousand net of tax) related to the Company's completed acquisition of Provident Bancorp, Inc. and its wholly owned subsidiary BankProv (collectively, "Provident");

● Non-recurring fees for business line expansion of $500 thousand ($367 thousand net of tax); and

● Tax expense and a modified endowment contract penalty of $50 thousand related to the surrender of BOLI policies from policies acquired from Provident.

The material one-time charges for the quarter ended March 31, 2025 include:

● Pension expense related to the final liquidation of the employee pension plan totaling $1.2 million ($884 thousand net of tax); and

● Tax expense and a modified endowment contract penalty related to the surrender of BOLI policies of $154 thousand.

***Interest and Dividend Income.*** Interest and dividend income increased $28.8 million, or 37.5%, to $105.7 million for the quarter ended March 31, 2026, from $76.9 million for the quarter ended March 31, 2025, primarily due to a $28.6 million, or 40.0% increase in interest and fees on loans. The increase in interest and fees on loans was primarily due to an increase of $1.72 billion, or 39.5%, in the average balance of the loan portfolio to $6.09 billion for the quarter ended March 31, 2026, from $4.37 billion for the quarter ended March 31, 2025, reflecting the growth of our commercial loan portfolio.

Average interest-earning assets increased $1.79 billion, or 36.7% to $6.68 billion for the quarter ended March 31, 2026, from $4.89 billion for the quarter ended March 31, 2025. The significant increase in the average balance of loans was a result of the Provident acquisition which closed during the quarter ending December 31, 2025. The yield on interest-earning assets was 6.41% for the quarter ended March 31, 2026, compared to 6.38% for the quarter ended March 31, 2025, representing a 3 basis point expansion. The ending balance of gross loans of $6.21 billion, is $119.7 million or 2.0%, higher than the average balance of gross loans at the end of the quarter, primarily the result of one large cannabis loan of $115.0 million closing near the end of the quarter, which includes a credit enhancement on a first out basis, and did not have a significant impact on loan yields during the quarter.

***Interest Expense.*** Total interest expense increased $7.5 million, or 22.5%, to $40.8 million for the quarter ended March 31, 2026, from $33.3 million for the quarter ended March 31, 2025.

Interest expense on deposit accounts increased $7.3 million, or 22.8%, to $39.6 million for the quarter ended March 31, 2026, from $32.2 million for the quarter ended March 31, 2025. The increase was due to the Provident acquisition and organic growth which resulted in increases in the average balance of money market accounts of $638.6 million, 59.5%, to $1.71 billion for the quarter ended March 31, 2026, from $1.07 billion for the quarter ended March 31, 2025 and certificates of deposit and individual retirement accounts of $518.0 million, or 26.2%, to $2.50 billion for the quarter ended March 31, 2026, from $1.98 billion for the quarter ended March 31, 2025; offset partially by decreases in the weighted average rate on certificates of deposit and individual retirement accounts of 60 basis points to 3.99% for the quarter ended March 31, 2026, from 4.59% for the quarter ended March 31, 2025 and money market accounts of 28 basis points to 3.02% for the quarter ended March 31, 2026, from 3.29% for the quarter ended March 31, 2025.

[**Table of Contents**](#TOC)

***Net Interest Income.*** Net interest income increased $21.3 million, or 49.0%, to $64.9 million for the quarter ended March 31, 2026, from $43.5 million for the quarter ended March 31, 2025, primarily due to a $1.79 billion, or 36.7%, increase in the average balance of interest-earning assets to $6.68 billion for the quarter ended March 31, 2026, from $4.89 billion for the quarter ended March 31, 2025 and a decrease in the weighted average rate on interest-bearing liabilities of 44 basis points from 3.63% for the quarter ended March 31, 2025 to 3.19% for the quarter ended March 31, 2026. These increases were offset partially by a $1.46 billion increase in the average balance of interest-bearing liabilities to $5.19 billion for the quarter ended March 31, 2026, from $3.73 billion for the quarter ended March 31, 2025.

***Provision for Credit Losses.*** Based on management's analysis of the adequacy of the ACL, a total provision for credit losses of $6.3 million was recorded for the quarter ended March 31, 2026, of which $6.4 million related to the provision for credit losses on loans, compared to a total provision for credit losses of $1.2 million for the quarter ended March 31, 2025, which included a $947 thousand provision for credit losses on loans. The provision for credit losses on unfunded commitments decreased $265,000, or 125.6%, during the three months ended March 31, 2026, as a result of an increase in net unfunded commitments of $58 million in the prior quarter, compared to a $14.5 million increase in the current quarter. The increase of $5.2 million, or 446.5%, in the total provision for credit losses was primarily due to growth in the balance of commercial and industrial loans, larger peer commercial real estate credit losses realized in the prior quarter impacting quantitative reserves, and an elevated qualitative factor risk grade for the commercial and industrial loan portfolio.

The Company recorded charge-offs of $13.9 million during the quarter ended March 31, 2026, compared to $1.6 million during the quarter ended March 31, 2025. The increase in charge-offs was primarily driven by two large charge-offs of PCD commercial and industrial loans, in amounts of $10.6 million and $1.8 million. These loans were previously reserved for through purchase accounting adjustments as of the acquisition date and resulted in no additional loss to the Company.

***Noninterest Income.*** Noninterest income increased $631 thousand, or 16.3%, to $4.5 million for the quarter ended March 31, 2026, from $3.9 million for the quarter ended March 31, 2025. The increase resulted primarily from increases in customer service fees of $573 thousand, or 22.4%, due to higher loan and cash management fees. The table below sets forth our noninterest income for the quarters ended March 31, 2026 and 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended**  | **Three Months Ended**  | **Change** | **Change** |
|  | **March 31, 2026** | **March 31, 2025** | **Amount** | **Percent** |
|  | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** |
| Customer service fees | $3131 | $2558 | $573 | 22.40% |
| Increase in cash surrender value of BOLI | 853 | 1031 | (178) | (17.26)% |
| Mortgage banking income | 119 | 149 | (30) | (20.13)% |
| Swap contract income | 201 | 88 | 113 | 128.41% |
| (Loss) gain on sale of loans, net | (1) | 27 | (28) | (103.70)% |
| Other income | 210 | 29 | 181 | 624.14% |
| &nbsp;&nbsp;Total noninterest income | $4513 | $3882 | $631 | 16.25% |

---

***Noninterest Expense.*** Noninterest expense increased $14.0 million, or 48.9%, to $42.7 million for the quarter ended March 31, 2026, from $28.7 million for the quarter ended March 31, 2025. Salaries and employee benefit expenses increased $6.3 million, or 33.0%, resulting primarily from a $4.5 million increase in employee compensation, an $819 thousand increase in medical and dental benefits and $803 thousand increase in employee bonus expense due to a full quarter of increased headcount from the Provident acquisition and continued growth, along with a $495 thousand increase in stock compensation expense as result from grants made subsequent to March 31, 2025; partially offset by a $1.2 million decrease in pension expense due to completion of the plan liquidation during 2025. General and administrative expenses increased $2.2 million, or 156.2%, primarily due to a full quarter's worth of core deposit intangible amortization resulting in an $854 thousand increase, a $353 thousand increase in tax credit amortization expenses resulting from additional investments and a $124 thousand increase in loan workout expenses related to the acquired Provident enterprise value loan portfolio. Director and professional service fees increased $1.9 million, or 88.5%, resulting from director stock compensation from grants made subsequent to March 31, 2025 of $948 thousand and the non-recurring $500 thousand business line expansion fee.

[**Table of Contents**](#TOC)

Data processing expenses increased $1.7 million, or 60.5%, primarily the result of our significant investment in technology and systems, as well as a full quarter of increased transactional volume from the Provident acquisition.

The table below sets forth our noninterest expense for the quarters ended March 31, 2026 and 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended**  | **Three Months Ended**  | **Change** | **Change** |
|  | **March 31, 2026** | **March 31, 2025** | **Amount** | **Percent** |
|  | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** |
| Salaries and employee benefits | $25468 | $19149 | $6319 | 33.00% |
| Data processing expenses | 4439 | 2765 | 1674 | 60.54% |
| Director and professional service fees | 4049 | 2148 | 1901 | 88.50% |
| Occupancy and equipment expenses | 2491 | 1580 | 911 | 57.66% |
| FDIC and state insurance assessments | 1152 | 813 | 339 | 41.70% |
| Marketing and charitable contribution expenses | 1033 | 846 | 187 | 22.10% |
| Merger and acquisition expenses | 534 | - | 534 | 100.00% |
| General and administrative expenses | 3535 | 1380 | 2155 | 156.16% |
| &nbsp;&nbsp;Total noninterest expense | $42701 | $28681 | $14020 | 48.88% |

---

***Income Tax Expense.*** Income tax expense increased $454 thousand, or 9.2%, to $5.4 million for the quarter ended March 31, 2026, from $4.9 million for the quarter ended March 31, 2025. The increase was due to the increase in pretax income of $2.8 million, or 15.8%. The effective tax rate was 26.4% and 28.0% for the quarter ended March 31, 2026 and 2025, respectively, with the decline attributable to increased investments in tax credits.

[**Table of Contents**](#TOC)

***Average Balances and Yields.*** The following table sets forth average balance sheets, average yields and costs, and certain other information for the periods indicated. No tax-equivalent yield adjustments have been made, as the effects would be immaterial. Non-accrual loans were included in the computation of average balances. All average balances are daily average balances. The yields set forth below include the effect of deferred fees, discounts, and premiums that are amortized or accreted to interest income or interest expense; such fees, discounts and premiums were not material for the periods presented.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended**  | **Three Months Ended**  | **Three Months Ended**  | **Three Months Ended**  | **Three Months Ended**  | **Three Months Ended**  |
|  | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2025** | **March 31, 2025** | **March 31, 2025** |
|  | **Average** <br>**Outstanding** <br>**Balance** | <br>**Interest** | <br>**Average** <br>**Yield/Rate** <sup>(4)</sup> | **Average** <br>**Outstanding** <br>**Balance** | <br>**Interest** | <br>**Average** <br>**Yield/Rate** <sup>(4)</sup> |
|  | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** |
| **Interest-earning assets:** |  |  |  |  |  |  |
| Loans | $6090227 | $100042 | 6.66% | $4366206 | $71440 | 6.64% |
| Securities | 273308 | 2708 | 4.02% | 230406 | 2290 | 4.03% |
| Other investments <sup>(5)</sup> | 28275 | 265 | 3.80% | 27529 | 219 | 3.23% |
| Short-term investments <sup>(5)</sup> | 290385 | 2671 | 3.73% | 264343 | 2902 | 4.45% |
| &nbsp;&nbsp;Total interest-earning assets | 6682195 | 105686 | 6.41% | 4888484 | 76851 | 6.38% |
| Non-interest-earning assets | 375966 |  |  | 296729 |  |  |
| Allowance for credit losses | (88102) |  |  | (38685) |  |  |
| &nbsp;&nbsp;Total assets | $6970059 |  |  | $5146528 |  |  |
| **Interest-bearing liabilities:** |  |  |  |  |  |  |
| Savings accounts | $207681 | 263 | 0.51% | $113750 | 46 | 0.16% |
| NOW accounts | 639347 | 2006 | 1.27% | 470469 | 1074 | 0.93% |
| Money market accounts | 1711672 | 12732 | 3.02% | 1073041 | 8716 | 3.29% |
| Certificates of deposit and individual retirement accounts | 2497213 | 24578 | 3.99% | 1979184 | 22403 | 4.59% |
| &nbsp;&nbsp;Total interest-bearing deposits | 5055913 | 39579 | 3.17% | 3636444 | 32239 | 3.60% |
| FHLB borrowings | 135441 | 1239 | 3.71% | 91168 | 1086 | 4.83% |
| &nbsp;&nbsp;Total interest-bearing liabilities | 5191354 | 40818 | 3.19% | 3727612 | 33325 | 3.63% |
| Non-interest-bearing deposits | 819830 |  |  | 571552 |  |  |
| Other non-interest-bearing liabilities | 97370 |  |  | 90023 |  |  |
| &nbsp;&nbsp;Total liabilities | 6108554 |  |  | 4389187 |  |  |
| Shareholders' equity | 861505 |  |  | 757341 |  |  |
| &nbsp;&nbsp;Total liabilities and shareholders' equity | $6970059 |  |  | $5146528 |  |  |
| Net interest income |  | $64868 |  |  | $43526 |  |
| Net interest rate spread <sup>(1)</sup> |  |  | 3.22% |  |  | 2.75% |
| Net interest-earning assets <sup>(2)</sup> | $1490841 |  |  | $1160872 |  |  |
| Net interest margin <sup>(3)</sup> |  |  | 3.94% |  |  | 3.61% |
| Average interest-earning assets to interest-bearing liabilities | 128.72% |  |  | 131.14% |  |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Net interest rate spread represents the difference between the weighted average yield on interest-earning assets and the weighted average rate of interest-bearing liabilities.

&nbsp;&nbsp;&nbsp;&nbsp;(2) Net interest-earning assets represent total interest-earning assets less total interest-bearing liabilities.

&nbsp;&nbsp;&nbsp;&nbsp;(3) Net interest margin represents net interest income divided by average total interest-earning assets.

&nbsp;&nbsp;&nbsp;&nbsp;(4) Annualized.

&nbsp;&nbsp;&nbsp;&nbsp;(5) Other investments are comprised of FRB stock, FHLB stock and swap collateral accounts. Short-term investments are comprised of cash and cash equivalents.

[**Table of Contents**](#TOC)

***Rate/Volume Analysis.*** The following table presents the effects of changing rates and volumes on our net interest income for the periods indicated. The rate column shows the effects attributable to changes in rate (changes in rate multiplied by prior volume). The volume column shows the effects attributable to changes in volume (changes in volume multiplied by prior rate). The total column represents the sum of the prior columns. For purposes of this table, changes attributable to both rate and volume, which cannot be segregated, have been allocated proportionately based on the changes due to rate and the changes due to volume. There were no out-of-period items or adjustments required to be excluded from the table below.

---

| | | | |
|:---|:---|:---|:---|
|  | **Three Months Ended**  | **Three Months Ended**  | **Three Months Ended**  |
|  | **March 31, 2026 vs. 2025** | **March 31, 2026 vs. 2025** | **March 31, 2026 vs. 2025** |
|  | **Increase (Decrease) Due to** | **Increase (Decrease) Due to** | |
|  | <br>**Volume** | <br>**Rate** | **Total** <br>**Increase**<br>**(Decrease)** |
|  | **(In thousands)** | **(In thousands)** | **(In thousands)** |
| **Interest-earning assets:** |  |  |  |
| Loans | $28319 | $283 | $28602 |
| Securities | 425 | (7) | 418 |
| Other investments | 6 | 40 | 46 |
| Short-term investments | 358 | (589) | (231) |
| &nbsp;&nbsp;Total interest-earning assets | 29108 | (273) | 28835 |
| **Interest-bearing liabilities:** |  |  |  |
| Savings accounts | 61 | 156 | 217 |
| NOW accounts | 456 | 476 | 932 |
| Money market accounts | 4678 | (662) | 4016 |
| Certificates of deposit and individual retirement accounts | 4338 | (2163) | 2175 |
| &nbsp;&nbsp;Total interest-bearing deposits | 9533 | (2193) | 7340 |
| Federal Home Loan Bank advances | 293 | (140) | 153 |
| &nbsp;&nbsp;Total interest-bearing liabilities | 9826 | (2333) | 7493 |
| Change in net interest income | $19282 | $2060 | $21342 |

---

**Management of Market Risk**

***General*.** The Bank's most significant form of market risk is interest rate risk as the majority of our assets and liabilities are sensitive to changes in interest rates. Therefore, a principal part of our operations is to manage interest rate risk and limit the exposure of our financial condition and results of operations to changes in market interest rates. Our ERM Committee is responsible for evaluating the interest rate risk inherent in our assets and liabilities, for determining the level of risk that is appropriate, given our business strategy, operating environment, capital, liquidity and performance objectives, and for managing this risk consistent with the policy and guidelines approved by our Board of Directors. The ERM Committee meets at least quarterly, is comprised of directors, executive officers and certain members of senior management, and reports to the full Board of Directors on at least a quarterly basis. We currently utilize a third-party modeling program, prepared on a quarterly basis, to evaluate our sensitivity to changing interest rates, given our business strategy, operating environment, capital, liquidity and performance objectives, and for managing this risk consistent with the guidelines approved by the Board of Directors.

We have sought to manage our interest rate risk in order to minimize the exposure of our earnings and capital to changes in interest rates. We have implemented the following strategies to manage our interest rate risk:

● maintaining capital levels that exceed the thresholds for well-capitalized status under federal regulations;

● maintaining a prudent level of liquidity;

● maintaining a prudent level of off-balance sheet funding capacity;

● growing our volume of core deposit accounts;

● utilizing our AFS securities portfolio and interest rate swaps as part of our balance sheet asset and liability and interest rate risk management strategy to reduce the impact of movements in interest rates on net interest income and the economic value of equity;

● managing our utilization of wholesale funding with borrowings from the FHLB and brokered deposits in a prudent manner;

[**Table of Contents**](#TOC)

● continuing to diversify our loan portfolio by adding more commercial-related loans and consumer loans, which typically have shorter maturities and/or balloon payments; and

● continuing to price our one-to-four family residential real estate loan products in a way that encourages borrowers to select our adjustable-rate loans as opposed to longer-term, fixed-rate loans.

Shortening the average term of our interest-earning assets by increasing our investments in shorter-term assets, as well as originating loans with variable interest rates, helps to match the maturities and interest rates of our assets and liabilities better, thereby reducing the exposure of our net interest income to changes in market interest rates.

On occasion, we have employed various financial risk methodologies that limit, or "hedge," the adverse effects of rising or decreasing interest rates on our loan portfolios and short-term liabilities. We also engage in hedging strategies with respect to arrangements where our customers swap floating interest rate obligations for fixed interest rate obligations, or vice versa. Our hedging activity varies based on the level and volatility of interest rates and other changing market conditions.

***Net Interest Income.*** We analyze our sensitivity to changes in interest rates through a net interest income model. Net interest income is the difference between the interest income we earn on our interest-earning assets, such as loans and securities, and the interest we pay on our interest-bearing liabilities, such as deposits and borrowings. We estimate what our net interest income would be for a 12-month period. We then calculate what the net interest income would be for the same period under the assumptions that the United States Treasury yield curve increases or decreases instantaneously by various basis point increments, with changes in interest rates representing immediate and permanent, parallel shifts in the yield curve. A basis point equals one-hundredth of one percent, and 100 basis points equals one percent. An increase in interest rates from 3% to 4% would mean, for example, a 100-basis point increase in the "Change in Interest Rates" column below.

The following table sets forth, as of March 31, 2026, the calculation of the estimated changes in our net interest income that would result from the designated immediate changes in the United States Treasury yield curve.

---

| | | |
|:---|:---|:---|
| **At March 31, 2026** | **At March 31, 2026** | **At March 31, 2026** |
| **Change in Interest Rates**<br>**(basis points)** <sup>(1)</sup> | **Net Interest Income**<br> **Year 1 Forecast** | **Year 1 Change from**<br>**Level** |
| **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** |
| 300 | 275608 | 5.5% |
| 200 | 271756 | 4.0% |
| 100 | 267723 | 2.5% |
| Level | 261269 | —% |
| (100) | 257262 | (1.5)% |
| (200) | 254567 | (2.6)% |
| (300) | 252994 | (3.2)% |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Assumes an immediate uniform change in interest rates at all maturities.

The table above indicates that as of March 31, 2026, we would have experienced a 4.0% increase in net interest income in the event of an instantaneous parallel 200 basis point increase in market interest rates and a 2.6% decrease in net interest income in the event of an instantaneous 200 basis point decrease in market interest rates.

***Economic Value of Equity ("EVE")*.** We also compute amounts by which the net present value of our assets and liabilities, or EVE, would change in the event of a range of assumed changes in market interest rates. This model uses a discounted cash flow analysis and an option-based pricing approach to measure the interest rate sensitivity of net portfolio value.

The model estimates the economic value of each type of asset, liability and off-balance sheet contract under the assumptions that the United States Treasury yield curve increases instantaneously by 100, 200 and 300 basis point increments or decreases instantaneously by 100, 200 and 300 basis point increments, with changes in interest rates representing immediate and permanent, parallel shifts in the yield curve.

[**Table of Contents**](#TOC)

The following table sets forth, as of March 31, 2026, the calculation of the estimated changes in our EVE that would result from the designated immediate changes in the United States Treasury yield curve.

---

| | | | |
|:---|:---|:---|:---|
| | | **Estimated Increase**  | **Estimated Increase**  |
| | | **(Decrease) in EVE** | **(Decrease) in EVE** |
| <br>**At March 31, 2026**<br>**Change in Interest Rates (basis points)** <sup>(1)</sup> | <br>**Estimated** <br>**EVE** <sup>(2)</sup> | **Amount** | **Percent** |
| **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** |
| 300 | 1160382 | (120052) | (9.4)% |
| 200 | 1210126 | (70308) | (5.5)% |
| 100 | 1257033 | (23401) | (1.8)% |
| Level | 1280434 | N/A | —% |
| (100) | 1291870 | 11436 | 0.9% |
| (200) | 1272992 | (7442) | (0.6)% |
| (300) | 1221726 | (58708) | (4.6)% |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Assumes an immediate uniform change in interest rates at all maturities.

The table above indicates that as of March 31, 2026, we would have experienced a 5.5% decrease in EVE in the event of an instantaneous parallel 200 basis point increase in market interest rates and a 0.6% decrease in EVE in the event of an instantaneous 200 basis point decrease in market interest rates.

Certain shortcomings are inherent in the methodologies used in the above interest rate risk measurements. Modeling changes require making certain assumptions that may or may not reflect the manner in which actual yields and costs respond to changes in market interest rates. The net interest income and EVE tables presented assume that the composition of our interest-sensitive assets and liabilities existing at the beginning of a period remains constant over the period being measured and assumes that a particular change in interest rates is reflected uniformly across the yield curve regardless of the duration or repricing of specific assets and liabilities. Accordingly, although the tables provide an indication of our interest rate risk exposure at a particular point in time, such measurements are not intended to and do not provide a precise forecast of the effect of changes in market interest rates, and actual results may differ. Interest rate risk calculations also may not reflect the fair values of financial instruments. For example, decreases in market interest rates can increase the fair values of our loans, deposits, derivatives and borrowings.

#### Liquidity and Capital Resources
Liquidity describes our ability to meet the financial obligations that arise in the ordinary course of business. Liquidity is primarily needed to meet the borrowing and deposit withdrawal requirements of our customers and to fund current and planned expenditures. Our primary sources of funds are deposits, principal and interest payments on loans and securities, and proceeds from maturities of securities. We are also able to borrow from the FHLB and the Discount Window at the Federal Reserve Bank of Boston ("FRB"). As of March 31, 2026, we had outstanding advances of $189.7 million from the FHLB and an unused borrowing capacity of $892.7 million with the FHLB. At March 31, 2026, the Bank had $1.01 billion available from a line under the Borrower in Custody ("BIC") program at the FRB. Additionally, as of March 31, 2026, we had $570.1 million of brokered deposits and pursuant to our internal liquidity policy, which allows us to utilize brokered deposits up to 25.0% of our total assets, we had an additional capacity of up to approximately $1.2 billion of brokered deposits.

While maturities and scheduled amortization of loans and securities are predictable sources of funds, deposit flows and loan prepayments are greatly influenced by general interest rates, economic conditions, and competition. Our most liquid assets are cash and short-term investments. The levels of these assets are dependent on our operating, financing, lending, and investing activities during any given period.

Our cash flows are comprised of three primary classifications: cash flows from operating activities, investing activities, and financing activities.

[**Table of Contents**](#TOC)

At March 31, 2026, we had $11.3 million in outstanding commitments to originate loans. In addition, we had $822.8 million in unused lines of credit to borrowers, $386.7 million in unconditionally cancelable unadvanced mortgage warehouse loans, $380.4 million in unadvanced construction loans and $9.0 million in letters of credit outstanding.

Non-brokered certificates of deposit due within one year of March 31, 2026 totaled $1.93 billion, or 31.6%, of total deposits. If these deposits do not remain with us, we may be required to seek other sources of funds, including brokered deposits, FHLB advances and FRB borrowings. Depending on market conditions, we may be required to pay higher rates on such deposits or other borrowings than we currently pay on the non-brokered certificates of deposit due on or before March 31, 2027, or on our other interest-bearing deposit accounts. We believe, however, based on historical experience and current market interest rates that we will retain, upon maturity, a large portion of our certificates of deposit with maturities of one year or less as of March 31, 2026.

Our primary investing activity is originating loans. During the three months ended March 31, 2026, we originated $226.7 million of loans, net of repayments.

Financing activities consist primarily of activity in deposit accounts and FHLB advances. We experienced net increases in deposits of $243.5 million for the three months ended March 31, 2026. At March 31, 2026 and December 31, 2025, the level of brokered deposits was $570.1 million and $535.7 million, respectively. Deposit flows are affected primarily by the overall level of interest rates and the interest rates and products offered by us and our competitors. FHLB advances decreased $6.5 million during the three months ended March 31, 2026.

For additional information, see the consolidated statements of cash flows for the three months ended March 31, 2026 and 2025 included as part of the consolidated financial statements appearing elsewhere in this Form 10-Q.

We are committed to maintaining a strong liquidity position. We continuously monitor our liquidity position and adjustments are made to the balance between sources and uses of funds as deemed appropriate by management. Liquidity risk management is an important element in our asset/liability management process. We regularly model liquidity stress scenarios to assess potential liquidity outflows or funding problems resulting from economic disruptions, volatility in the financial markets, unexpected credit events or other significant occurrences deemed problematic by management. These scenarios are incorporated into our contingency funding planning process, which provides the basis for the identification of our liquidity needs. We anticipate that we will have sufficient funds to meet our current funding commitments. In addition, based on our deposit retention experience and current pricing strategy, we anticipate that a significant portion of maturing time deposits will be retained.

As of March 31, 2026, Needham Bank and NB Bancorp, Inc. exceeded all of their regulatory capital requirements, and were categorized as well-capitalized at that date. Management is not aware of any conditions or events since the most recent notification of well-capitalized status that would change our category. See Note 11 of the notes to consolidated financial statements.

**Impact of Inflation and Changing Prices**

The consolidated financial statements and related data presented in this Form 10-Q have been prepared in accordance with U.S. GAAP, which requires the measurement of financial position and operating results in terms of historical dollars without considering changes in the relative purchasing power of money over time due to inflation. The primary impact of inflation on our operations is reflected in increased operating costs. Unlike most industrial companies, virtually all of the assets and liabilities of a financial institution are monetary in nature. As a result, interest rates, generally, have a more significant impact on a financial institution's performance than does inflation. Interest rates do not necessarily move in the same direction or to the same extent as the prices of goods and services.

[**Table of Contents**](#TOC)

#### Item 3. Quantitative and Qualitative Disclosures About Market Risk
The information called for by this Item is incorporated by reference to the discussion of market risk in Item 2 - "Management's Discussion and Analysis of Financial Condition and Results of Operations - Management of Market Rate Risk."

#### Item 4. Controls and Procedures
An evaluation was performed under the supervision and with the participation of the Company's management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of the Company's disclosure controls and procedures (as defined in Rule 13a-15(e) promulgated under the Securities and Exchange Act of 1934, as amended) as of March 31, 2026. Based on that evaluation, the Company's management, including the Chief Executive Officer and the Chief Financial Officer, concluded that the Registrant's disclosure controls and procedures were effective.

During the quarter ended March 31, 2026, there have been no changes in the Company's internal controls over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

**Part II – Other Information**

#### Item 1. Legal Proceedings
The Company is subject to various legal actions arising in the normal course of business. In the opinion of management, the resolution of these legal actions is not expected to have a material adverse effect on the Company's or the Bank's financial condition or results of operations.

#### Item 1A. Risk Factors
There have been no material changes in risk factors applicable to the Company from those disclosed in "Risk Factors" in Item 1A of the Company's Annual Report on Form 10-K for the year ended December 31, 2025.

#### Item 2. Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | <br>**Total Number**<br>**of Shares** | <br>**Average Price**<br>**Paid per Share (1)** | **Total Number of Shares**<br>**Purchased as Part of the**<br>**Publicly Announced**<br>**Share Repurchase Program** | **Maximum Number of Shares**<br>**That May Yet Be**<br>**Purchased Under the**<br>**Share Repurchase Program (2)** |
| January 1 - January 31, 2026 | 29918 | $20.65 | 29918 | 2258591 |
| February 1 - February 28, 2026 | 487015 | 21.91 | 516933 | 1771576 |
| March 1 - March 31, 2026 | 771576 | 21.36 | 1288509 | 1000000 |
| Total | 1288509 | $21.55 |  |  |

---

(1) Includes commissions paid and excise tax.

(2) On January 22, 2026, the Company announced a third stock repurchase program that authorizes the Company to purchase up to 2,288,509 shares, or 5%, of the Company's outstanding shares of common stock.

#### Item 3. Defaults Upon Senior Securities
None.

#### Item 4. Mine Safety Disclosures
Not applicable.

[**Table of Contents**](#TOC)

#### Item 5. Other Information
During the three months ended March 31, 2026, none of the Company's directors or executive officers adopted or terminated any contract, instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any "non-Rule 10b5-1 trading arrangement" as that term is used in SEC regulations.

#### Item 6. Exhibits

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;31.1 | [Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](nbbk-20260331xex31d1.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;31.2 | [Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](nbbk-20260331xex31d2.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;32 | [Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](nbbk-20260331xex32.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;101.INS | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| &nbsp;&nbsp;&nbsp;&nbsp;101.SCH | XBRL Taxonomy Extension Schema Document |
| &nbsp;&nbsp;&nbsp;&nbsp;101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document |
| &nbsp;&nbsp;&nbsp;&nbsp;101.DEF | XBRL Taxonomy Extension Definition Linkbase Document |
| &nbsp;&nbsp;&nbsp;&nbsp;101.LAB | XBRL Taxonomy Extension Label Linkbase Document |
| &nbsp;&nbsp;&nbsp;&nbsp;101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document |
| &nbsp;&nbsp;&nbsp;&nbsp;Exhibit 104 | Cover Page Interactive Data File - The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |

---

[**Table of Contents**](#TOC)

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
|  | **NB BANCORP, INC.** |
| Date: May 8, 2026 | /s/ Joseph Campanelli |
|  | Joseph Campanelli |
|  | Chairman, President and Chief Executive Officer |
| Date: May 8, 2026 | /s/ Jean-Pierre Lapointe |
|  | Jean-Pierre Lapointe |
|  | Senior Executive Vice President and Chief Financial Officer |

---

## Exhibit 31.1

**Exhibit 31.1**

**Certification of Chief Executive Officer**

**Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002**

I, Joseph Campanelli, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this Quarterly Report on Form 10-Q of NB Bancorp, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the consolidated financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: | May 8, 2026 | /s/ Joseph Campanelli |
|  |  | Joseph Campanelli |
|  |  | Chairman, President and Chief Executive Officer |

---

------

## Exhibit 31.2

**Exhibit 31.2**

**Certification of Chief Financial Officer**

**Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002**

I, Jean-Pierre Lapointe, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this Quarterly Report on Form 10-Q of NB Bancorp, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the consolidated financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: | May 8, 2026 | /s/ Jean-Pierre Lapointe |
|  |  | Jean-Pierre Lapointe |
|  |  | Senior Executive Vice President and Chief Financial Officer |

---

------

## Ex-32

**Exhibit 32**

**Certification of Chief Executive Officer and Chief Financial Officer**

**Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

Joseph Campanelli, Chairman, President and Chief Executive Officer of NB Bancorp, Inc., (the "Company") and Jean-Pierre Lapointe, Executive Vice President and Chief Financial Officer of the Company, each certify in their capacity as an officer of the Company that they have reviewed the quarterly report on Form 10-Q for the quarter ended March 31, 2026 (the "Report") and that to the best of their knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. the Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: | May 8, 2026 | /s/ Joseph Campanelli |
|  |  | Joseph Campanelli |
|  |  | Chairman, President and Chief Executive Officer |
| Date:  | May 8, 2026 | /s/ Jean-Pierre Lapointe |
|  |  | Jean-Pierre Lapointe |
|  |  | Senior Executive Vice President and Chief Financial Officer |

---

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

------